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B VIRUS CIRCUMVENTS INNATE RESPONSES IN HUMAN CELLS 
  
by 
CHIH-LING ZAO 
Under the Direction of Julia K. Hilliard 
ABSTRACT 
 
B virus (Cercopithecine herpesvirus 1) is an alphaherpesvirus indigenous to 
macaque monkeys and is closely related to herpes simplex virus type 1 (HSV-1). Disease 
caused by B virus, which is often mild or asymptomatic in its natural host, the macaque 
monkey, is similar in infected macaques to HSV-1 infection in humans. When B virus 
zoonotically infects foreign hosts, e.g., humans, high morbidity and mortality are 
evidenced in > 80% of untreated cases. To explore the underlying reasons for differences 
in pathogenesis between B virus and HSV-1 infection in humans, human microarrays 
were used to comparatively examine global cellular gene expression patterns engaged as 
a result of infection of human foreskin fibroblasts (HFFs). Our results demonstrate that 
these closely related simplexvirus family members have divergent strategies to thwart 
host cell pathways related to innate defenses. In these studies, B virus did not induce 
detectable interferon, cytokine or chemokine genes, in sharp contrast to HSV-1, which 
induced innate immune responsive genes in infected cells. Although no innate immune 
response genes were found to be up-regulated by B virus infection, B virus induced I!B", 
which was the only gene found to be involved in the NF-!B signaling pathway
within the innate immunity biological network. Quantification of NF-!B p50 DNA 
binding activity in virus-infected nuclear extracts demonstrated that NF-!B p50 DNA 
binding activity was lower in B virus-infected cells. Suppression of I!B" in B virus 
infected cells by siRNA restored NF-!B-induced cytokine and chemokine expressions. 
Data presented here support the model that I!B" inhibits NF-!B regulated immune 
responsive genes in B virus-infected HFF cells, and this response differs from that 
observed in HFF cells infected with HSV-1. The result is that B virus alters the NF-!B 
regulated expression of cytokine and chemokine genes of HFF cells differently from 
HSV-1 early after infection. These differences in cytokine and chemokine expression 
may be associated with the delayed or reduced host responses observed in B virus 
infected humans and underlie the failure of adaptive responses in zoonotically infected 
humans.    
 
INDEX WORDS: B virus, innate immunity, HSV-1, microarray, NF-!B, I!B" 
 
 
 
 
 
 
 
 B VIRUS CIRCUMVENTS INNATE RESPONSES IN HUMAN CELLS 
 
by 
 
CHIH-LING ZAO 
 
 
 
A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
in the College of Arts and Sciences 
Georgia State University 
 
 
 
 
 
2007 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Chih-Ling Zao 
2007
 B VIRUS CIRCUMVENTS INNATE RESPONSES IN HUMAN CELLS  
 
by 
 
CHIH-LING ZAO 
 
 
 
 
 
 
 
 
 
 
 
 
 
                            
 
                              Major Professor:  Julia K. Hilliard 
                                                            Committee:          Teryl K. Frey 
                                                                                         Richard D. Dix 
                                                                                         Roberta Attanasio 
 
 
 
 
Electronic Version Approved: 
 
 
Office of Graduate Studies 
College of Arts and Sciences 
Georgia State University 
August 2007 
  
iv 
DEDICATION 
 
To my family, specially my mother and father, 
for their unconditional love and patience. 
 
Also to my heavenly Father, 
for His amazing love and blessings.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
v 
ACKNOWLEDGEMENTS 
 
 
 
With my deepest gratitude, I thank my mentor Dr. Julia Hilliard for her guidance, 
generosity and unfailing support.  Her curiosity, creativity and critical thinking toward 
science motivate me to finish my doctoral studies and become a virologist.  
Special thanks to my committee member Dr. Richard Dix, for his great support 
and insightful comments on my dissertation work. Thanks also to Dr. Teryl Frey and Dr. 
Roberta Attanasio, for the valuable review and participation in my dissertation 
committee.  
I am thankful to Dr. Peter Krug for training me to use BSL-3 & 4 facilities, and 
giving me helpful advise on my projects.  I also would like to acknowledge Dr. Yuan Liu, 
Ali A. Pirani, Dr. Kim M. Gernert, Dr. John Ward, Sonja Young, Birgit Neuhaus and 
Wei Shi for their collaboration and assistance.  
To all members in the B virus lab and friends from other labs in GSU, thanks for 
their help and friendship.   
Finally, to a special friend, Cecilia Po, for her faithful support through the years.   
  
 
 
 
 
 
 
 
 
 
 
  
vi 
TABLE OF CONTENTS 
 
ACKNOWLEDGEMENTS……………………………………………………….... v 
 
LIST OF TABLES………………………………………………………………….. 
 
viii 
 
LIST OF FIGURES……………………………………………………………........ 
 
ix 
 
SECTION 
 
  
            I. INTRODUCTION………………………………………………………... 1 
  
                    Part 1. Literature review………………………………………………..                                                                       1
  
                    Part 2. Research goals…………………………………………………. 30 
  
             II. MATERIALS AND METHODS 32 
  
                    Cells and viruses……………………………………………………..... 32 
  
                    Growth kinetics of viruses…………………………………………...... 32 
  
                    Microarray and data analysis………………………………………….. 33 
   
                    Biological function and network analysis……………………………... 34 
  
                    Real-time RT-PCR…………………………………………………….. 35 
  
                    Isolation of Neutrophils……………………………………………….. 36 
  
                    Neutrophil transmigration assay………………………………………. 37 
  
                    Virus infected cell supernatant-mediated inhibition of neutrophil    
                    transmigration…………………………………………………………. 
 
38 
  
                    ELISA for detection of IL-8…………………………………………… 38 
  
                    Quantification of NF-!B p50 nuclear translocation…………………... 39 
  
                    Preparation of nuclear extracts………………………………………… 39 
  
                    NF-!B p50 DNA binding activity assay……………………………..... 40 
  
                    Immunofluorescent staining…………………………………………… 41 
  
vii 
  
                   Knockdown I!B" by siRNA………………………………………….... 42 
  
           III. RESULTS……………………………………………………………….. 43 
  
                   Part 1. Development of a human cell culture model system to  
                   investigate the early host responses to  B virus infection……………… 
 
43 
  
                   Part 2. Identification of virus-mediated human host cell responses at 
                   the early infection time points to target immune cells…………………. 
 
61 
  
                   Part 3. Design of blocking strategies to circumvent early events in the  
                   infected cell to modulate immune responses…………………………... 
 
86 
  
           IV. DISCUSSION…………………………………………………………… 95 
  
                   Human cell culture model system of B virus infection………………… 95 
  
                   Adapted cell model system of B virus infection: macaque cells in 
                   culture…………………………………………………………………... 
 
96 
  
                   Microarray tools: snapshots in time of virus: host cell interactions…… 98 
  
                   Kinetic analysis of microarray data: observations of dynamic virus:  
                   host interactions………………………………………………………... 
 
100 
  
                   The lack of innate immune responses in B virus infected cells: stealth 
                   virus in the environment of the foreign host cell………………………. 
 
101 
  
                   Sequence events from cytoplasm to nucleus during the course of virus  
                   infection (Virus-specific regulatation of the NF-!B pathway )………... 
 
103 
  
                   Neutrophil chemotaxis during virus infection provides inflammatory 
                   responses that dampen virus replication……………………………...... 
 
105 
  
                   Conclusion……………………………………………………………... 108 
  
REFERENCES……………………………………………………………………… 110 
  
  
  
  
 
  
viii 
LIST OF TABLES 
 
 
Table 1. HSV induced signal transduction pathway review………………………. 18 
  
Table 2. Biological network affected by B virus and HSV-1 infection at 3 h p.i…. 57 
  
Table 3. Biological network affected by B virus and HSV-1 infection at 5 h p.i…. 58 
  
Table 4. Validation of microarray data with real-time RT-PCR…………………... 60 
  
Table 5. The average I!B" knockdown rate of samples collected from each time 
              point………………………………………………………………………. 
 
93 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ix 
LIST OF FIGURES 
 
 
Fig 1: Expression levels of ICP0 (a) and TK gene (b) from B virus and HSV-1 
          infected HFFs……………………………………………………………….. 
 
44 
  
Fig 2.: Hierarchical cluster analysis of DNA microarray data obtained from B   
           virus and HSV-1 infected cells post 1h, 3h, and 5h infection in HG-U133 
           set chips……………………………………………………………………. 
 
 
48 
  
Fig 3: Venn diagrams of differential and overlapped regulated host cell gene 
           Numbers between B virus and HSV-1 infected samples at 1, 3, and 5 h p.i. 
 
50 
  
Fig 4: Comparison of B virus and HSV-1 up-regulated genes functions at 3 h (a) 
          and 5 h (b) p. i……………………………………………………………… 
 
53 
  
Fig 5: Comparison of B virus and HSV-1 down-regulated genes functions at 3 h 
          (a) and 5 h (b) p.i…………………………………………………………… 
 
55 
  
Fig 6: Hierarchical cluster analysis of immune responsive genes with at least 2- 
          fold change genes…………………………………………………………... 
 
62 
  
Fig 7: Hierarchical cluster analysis of IFN-related genes from microarray data in 
          B virus and HSV-1 infected samples at 1, 3, and 5 h p.i…………………… 
 
64 
  
Fig 8: Hierarchical cluster analysis of cytokine genes from microarray data in B  
          virus and HSV-1 infected samples at 1, 3, and 5 h p.i………………………. 
 
66 
  
Fig 9: Neutrophil transmigration towards supernatants from B virus, HSV-1 and 
          mock infected HFFs………………………………………………………… 
 
68 
  
Fig 10: Quantification of transmigrated neutrophil numbers in B virus, HSV-1  
            and mock infected cell supernatants……………………………………….. 
 
69 
  
Fig 11: Comparison of IL-8 productions in B virus, HSV-1 and mock infected  
            cell supernatants………………………………………………………….... 
 
71 
  
Fig 12: B virus infected cell supernatants-mediated inhibition to IL-8- and  
            fMLP-induced neutrophil transmigration………………………………….. 
 
73 
  
Fig 13: HSV-1 infected cell supernatants-mediated inhibition to IL-8- and  
            fMLP-induced neutrophil transmigration………………………………….. 
 
74 
  
  
  
x 
Fig 14: Mock infected cell supernatants-mediated inhibition to IL-8- and fMLP- 
            induced neutrophil transmigration…………………………………………. 
 
75 
  
Fig 15: Quantitation of virus infected cell supernatants mediated inhibition to  
            IL-8-induced neutrophil transmigration……………………………….…... 
 
76 
  
Fig 16: Quantitation of virus infected cell supernatants mediated inhibition to 
            fMLP-induced neutrophil transmigration…………………………………. 
 
77 
  
Fig 17: Biological network for NF-!B regulated immune responsive genes     
            generated from HSV-1 3 h p.i. samples…………………………………… 
 
79 
  
Fig 18: Nuclear translocation NF-!B p50 in TNF-# treated HFFs……………….. 81 
  
Fig 19: Nuclear translocation NF-!B p50 in B virus and HSV-1 infected HFFs…. 82 
  
Fig 20: NF-!B p50 DNA binding activity in B virus and HSV-1 infected HFF  
            cell nuclear preparations………………………………………………….... 
 
84 
  
Fig 21: Hierarchical cluster analysis of transcription factor genes from 
            microarray data in B virus and HSV-1 infected samples at 1, 3, and 5 h 
            p.i……………………………………………………………………….….. 
 
 
85 
  
Fig 22: Hierarchical cluster analysis of NF- !B pathway related genes from  
            microarray data in B virus and HSV-1 infected samples at 1, 3, and 
            5 h p.i…………………………………………………………………….… 
 
 
87 
  
Fig 23: Kinetics of I!B" mRNA level corresponding to B virus and HSV-1  
            infection……………………………………………………………….…… 
 
89 
  
Fig 24: Immunofluorescent staining of I!B" in B virus infected cell nuclei…….... 90 
  
Fig 25: Immunofluorescent staining of I!B" in HSV-1 infected cell nuclei…….... 91 
  
Fig 26: Cytokine and chemokine gene expressions in B virus infected I!B" gene 
            knockdown HFF cells vs. B virus infected negative control siRNA-treated 
            HFF cells…………………………………………………………………... 
 
 
94 
  
  
  
 
 
 
  
xi 
LIST OF ABBREVIATIONS 
 
 
ANOVA analysis of variance 
  
AP1 activator protein 1 
  
APCs antigen-presenting cells 
  
BCL3 B-cell CLL/lymphoma 3 
  
BMBL Biosafety in Microbiological and Biomedical Laboratories 
  
DAG diacylglycerol  
  
ELISA enzyme-linked immunosorbent assay 
  
EMEM Eagles minimum essential medium 
  
FDR false discovery rate  
  
fMLP N-formylated peptides  
  
gD glycoprotein D  
  
HBSS Hanks balanced salt solution  
  
HFF human foreskin fibroblast  
  
h hour 
  
HSV-1 herpes simplex virus type 1 
  
HSV-2 herpes simplex virus type 2 
  
ICP infected cell protein 
  
IFN interferon 
  
I!B inhibitor of kappa light polypeptide gene enhancer in B cells 
  
IKK I!B kinase  
  
IL interleukin 
  
xii 
IP3 inositol-1,4.5-trisphosphate  
  
JAK Janus kinase 
  
JNK Jun N-terminal kinase  
  
LPS Lipopolysaccharide  
  
LTB4 leukotriene B4 
  
MAPK mitogen-activated protein kinase 
  
MEKK mitogen-activated protein kinase 
  
MHC major histocompatibility complex 
  
m.o.i. multiplicity of infection 
  
MPO myeloperoxidase 
  
NF!B nuclear factor of kappa light polypeptide gene enhancer in B cells 
  
NFKBIZ nuclear factor of kappa light polypeptide gene enhancer in B-cells  
inhibitor zeta  
  
NIK NF-!B inducing kinase 
  
NK cells natural killer cells 
  
PBS phosphate buffer saline  
  
PI(4,5)P2 phosphatidylinositol-4,5-biphosphate  
  
PKB or Akt protein kinase B  
  
PKC protein kinase C  
  
PMNs polymorphonuclear granulocytes 
  
p.i. post infection 
  
PTKs protein tyrosine kinases 
  
RMA Robust Multichip Analysis 
  
xiii 
RHD Rel Homology Domain  
  
SD standard deviation 
  
SOCS3 suppressor of cytokine signaling-3  
  
STATs signal transducers and activators of transcription 
  
Sup. Supernatant 
  
TGF-$ transforming growth factor 
  
TLRs Toll-like receptors  
  
TNF-# tumor necrosis factor-# 
  
VP virion polypeptide 
  
  
  
1 
SECTION I: INTRODUCTION 
 
 Part 1. Literature Review 
 
 An overview of B virus.  
B virus is named after the first B virus-infected patient, W.B., who was bitten by a 
monkey in 1932 and died from progressive encephalomyelitis 18 days later (139). 
Various names have been ascribed for this virus in the literature, including 
Cercopithecine herpesvirus 1, Herpesvirus simiae, monkey B virus, herpesvirus B and 
herpes B. It was the first nonhuman primate herpesvirus identified. The virion consists of 
a core containing a linear double-stranded DNA of about 157 kb (123), an 
icosadeltahedral capsid about 160-180 nm in diameter, an amorphous tegument 
surrounding the capsid, and an envelope exhibiting viral glycoprotein spikes on its 
surface (133) (92). It is endemic in Old World monkeys and usually causes asymptomatic 
or mild infection in these natural host animals. Only about 50 cases of B virus infection 
in humans have been identified so far. However, the death rate for B virus-infected 
humans was >80% before the advent of antiviral therapy (166) (30) .  
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Classification and characterization of B virus 
 
Classification and nomenclature. B virus belongs to the Herpesviridae family, 
Alphaherpesvirinae subfamily, and Simplexvirus genus. Herpesviridae has three 
subfamilies: alphaherpesvirinae, betaherpesvirinae, and gammaherpesvirinae. The 
members of alphaherpesvirinae have variable host ranges, relatively short reproductive 
cycles, efficient destruction of infected cells and the capacity to establish latency 
primarily in sensory ganglia. The betaherpesvirinae subfamily has a restricted host range, 
long reproductive cycle, and causes latent infection in secretory glands, lymphoreticular 
cells, kidneys, and other tissues. As for the gammaherpesvirinae, its host range is limited 
to the natural host. In vitro, all members of this subfamily replicate in lymphoblastoid 
cells. Because the biological, molecular and serological properties of B virus are similar 
to other members of alphaherpesviruses, herpes simplex virus types 1 (HSV-1) and 2 
(HSV-2) of humans, the International Committee on the Taxonomy of Viruses designated 
B virus as Cercopithecine herpesvirus 1 (131).  
 
Biological properties. The growth properties of B virus in natural hosts resemble HSV-1 
and HSV-2 in vivo (135) (137) (136) (23). In cell culture, B virus also has similar 
replication kinetics as HSV-1 and HSV-2 (166), although B virus replicates slightly more 
rapidly. Virus adsorption to susceptible cell surfaces occurs within 30 to 60 minutes, and 
an eclipse period of cell and viral activities is followed within 2 to 3 hours. The non-
enveloped capsid is transported into the nucleus where viral DNA genome is released. 
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Viral DNA replication takes place in the nucleus at approximately 4 hours (h) post 
infection (p.i.). Cellular proteins as well as virion components are required for viral DNA 
replication in permissive cells. Like other herpesviruses, the expression of five viral gene 
groups, #, $1, $2, %1,and %2 are tightly regulated. Progeny B virus can be detected as 
early as 6 hr p.i. (67). 
 
 The double-stranded genome of B virus strain E2490 is composed of 156,789 bp, 
slightly larger than HSV-1 (152kb) and HSV-2 (155kb) (123). The guanosine and 
cytosine (G+C) content is 74.5%, which is as high as HSV-1 and HSV-2.  The genome 
structure contains unique long (UL) and unique short (US) regions flanked by a pair of 
inverted repeats, inverted long repeats (RL) and inverted short (RS) repeats, separately.  
The repeats allow rearrangements of the unique regions, and thus, the virus genome can 
exist as a mixture of four isomers. There are 74 genes identified from the complete B 
virus genome with the amino acid identity between B virus and HSV proteins ranging 
from 26.6 to 87.7%. Because many of these viral polypeptides share common antigenic 
determinants, antibodies induced by B virus or HSV-1 are highly cross-reactive (66) (43). 
This makes serological diagnosis of B virus infection in human cases complicated when 
the patients are also HSV-1 and HSV-2 seropositive.    
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Host range and pathogenic properties 
 
Initial isolation of B virus. B virus was first isolated from a 29-year-old physician 
(W.B.) who died from the bites of a healthy-appearing Macacus mulatta monkey (rhesus) 
in 1932 (55) (139). Three days after the bites, the wounds on the patient’s left little and 
ring fingers became inflamed, and subsequently regional lymphangitis and lymphadenitis 
developed.  The patient was admitted to the hospital 6 days later with a fever of 101.4°F. 
Several small cloudy fluid-filled vesicles formed near the wounds over the next few days. 
Generalized abdominal cramping developed 10 days after infection and followed by 
marked hyperesthesia of the lower extremities associated with urinary retention 13 days 
after monkey bite. Analysis of the CSF indicated mononuclear pleocytosis along with an 
increased level of albumin and globulins. The patient’s condition deteriorated over the 
following days, as indicated by hyperesthesia of the upper extremities and respiratory 
paralysis. Death occurred 5 hours after the patient lapsed into a coma 18 days after 
infection.  
 
 The histological diagnosis was acute transverse myelitis with areas of focal 
necrosis and hemorrhage in the regional lymph nodes, spleen, and adrenal glands. 
Inflammatory exudates, composed of mononuclear cells, were noted in the gray and 
white matter of the spinal cord. Additional lesions in the medulla, pons, basal ganglia, 
internal capsule, uncinate gyrus, and frontal lobe were composed of perivascular 
mononuclear cell infiltrates. The cause of death was listed as encephalomyelitis. Two 
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research groups, led by Gay and Sabin (55) (139), obtained samples from patient W.B. 
and both reported the existence of an ultrafilterable agent recovered from neurological 
tissues that was lethal to rabbits but not rhesus macaques. The pathologic manifestations 
of the agent in diseased rabbits demonstrated many features in common with those in the 
human disease. Gay and Holden reported the agent to be antigenically related to HSV and 
designated it “W virus” after the first initial of the patient. Sabin and Wright designated 
the isolated “B virus” after the second initial of the patient. The name B virus was widely 
adopted ever since.  
 
Human B virus infection. To date, fewer than 50 human cases of B virus infection have 
been documented. Two thirds have occurred in the United States and the others have 
been reported in Canada and Great Britain. The actual number of human cases may be 
underestimated, particularly if hypothesized asymptomatic cases are considered (91) (11) 
(70) (51), and in addition, the lack of confirmed human cases in Asian countries where 
humans and monkeys have a high contact frequency. The well documented routes of B 
virus infection in human cases include monkey bites (37) (139) (18) (73) (20) (119) (70) 
(36), monkey scratches (37) (91), exposure to tissue culture-bottle cuts (73), exposure to 
the tissues during autopsies of monkeys (37), wound contamination with monkey saliva 
(138), cage scratch (70) (149), needlestick injuries (37) (5), mucosal splash (127), 
human-to-human contact (70), possible aerosol (113) (72), and possible reactivation of B 
virus (47). 
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 Human B virus associated disease generally occurs within 1 month after exposure 
with an incubation period of a few days to weeks (69), but this can occur after even years 
have passed (47). The development of disease is thought to depend on the site of 
exposure and the amount of virus inoculated. Vesicular lesions have not been consistently 
found at the site of exposure. Patients often start with general flu-like symptoms of fever, 
muscle aches, fatigue and headache. Other variable symptoms include regional 
lymphadenitis, lymphangitis, nausea, vomiting, abdominal pain and hiccups. 
Neurological signs develop when the virus spreads along the nerves of the peripheral 
nervous system (PNS) to the central nervous system (CNS). Once the spinal cord or brain 
is infected by the virus, most patients die even with antiviral therapy intervention. Deaths 
are often attributed to respiratory failure associated with ascending paralysis (119) (70) 
(161). The possibility of asymptomatic or mild B virus infection in humans has been 
suggested, but it is considered rare if it occurs at all (51). Nonetheless, one case in which 
the disease occurred years after the initial exposure suggests that B virus is capable of 
establishing latent infection in humans (47). 
 
B virus infection in natural hosts, macaques. Besides humans, B virus infects a broad 
range of mammalian species, including Old World monkeys and New World monkeys. 
Old World monkeys of the genus Macaca are natural hosts of B virus, and almost all of 
this genus naturally exist in Asia. The most commonly reported B virus infections are 
found in the rhesus and cynomolgus macaque (M. Facicularis), two species used 
extensively in biomedical research. Other macaque monkeys including stumptail (M. 
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artoides), pig-tailed (M. nemestrina), Japanese (M. fuscata), bonnet (M. radiata), and 
Taiwan (M. cyclopis) have also been reported to naturally carry B virus (161). The 
prevalence of serum-detected B virus-induced antibodies in both wild and captive adult 
macaques can reach up to 70-100% (145) (117) (119) (162) (69). The routes of 
transmission are primarily through sexual activity and bites.  
 
 Like HSV infection in humans, B virus infection in monkeys is life-long and can 
remain latent in the sensory ganglia. Intermittent reactivation and shedding of viruses in 
saliva or genital secretions may occur, particularly during periods of stress or 
immunosuppression (161). Most infected macaques are asymptomatic. Oral herpetic 
lesions similar to HSV infection in humans, such as gingivostomatitis, oral and lingual 
ulcers, and conjunctivitis have been described, which usually heal spontaneously in 7 to 
14 days (161). In rare instances, systemic illness has even been reported, including the 
occurrence of ulcerative lesions in the mouth, esophagus, and stomach; diffused necrosis 
of the liver, spleen, and adrenal glands; cerebral infarction; interstitial hemorrhagic 
pneumonia and focal hepatitis, but most of these cases appear to be associated with 
immunosuppression (96) (34) (45).   
 
Natural host immune responses  
 
Host immunity in B virus infection. The host immune responses induced by B virus 
infection are far from being fully understood, but there is significantly more knowledge 
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of humoral antibody responses than of innate or cellular immune responses. Localized 
infection in skin and muscles usually results in vesicular rash in both the natural and 
foreign hosts. Virus infection in natural hosts usually heals spontaneously in 7 to 14 days, 
and virus spread is facilitated via travel through the PNS to enter the sensory ganglia for 
life-long latency. B virus infection in foreign hosts, however, can cause focal necrosis 
and hemorrhage in regional lymph nodes after virus exposure in the primary infected 
sites. Virus travels to the CNS by way of the PNS, centralizing in a small region of the 
cervical spinal cord causing focal lesions. In some human cases, dissolution of the cord in 
the region where the virus resides has been observed (139) (119) (161) (166). Whether 
the destruction is due to an immune response, lytic replication, or a combination of both 
remains unclear. Although little is known about cell-mediated immune responses induced 
by B virus infection in both natural and foreign hosts, a humoral immune response, 
initially IgM production, can be detected within 7 to 10 days p.i. with IgG subsequently 
appearing on day 14 p.i. in macaques (85) (166), but in zoonotically infected humans 
these responses appear to be delayed and at lower levels. Neutralizing antibodies appear 
both in the natural and foreign hosts, but at significantly lower titers in foreign hosts. The 
cause of this disparity in antibody responses is not known presently. 
 
Host innate immunity in HSV-1 infection. Immunological knowledge gathered from 
HSV-1 studies provides a paradigm to understand B virus pathogenesis, because these 
two viruses are evolutionarily closely related. In the case of HSV-1 infection, responding 
host defense includes both innate and adaptive immunity. Immune effector cells 
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including tissue macrophages, natural killer (NK) cells, circulating monocytes, 
polymorphonuclear granulocytes (PMNs) together with cytokines, provide nonspecific 
innate immune responses as a result of HSV-1 infection (168). Interestingly, hosts that 
lack the ability to mount an innate response suffer a high morbidity when infected with 
HSV.  
 
Resident macrophages are initially activated when HSV-1 first penetrates into the 
epithelium. Cytokines and chemokines secreted by the activated macrophages, especially 
cytokine tumor necrosis factor-# (TNF-#), induce numerous changes in endothelial cells 
of nearby blood capillaries. Cytokines induce the cell adhesion molecules, P-selectin and 
E-selectin, to appear on the endothelial cell surface, causing PMNs (mainly neutrophils) 
and monocytes to adhere to and roll on the endothelial surface in large numbers. 
Cytokines also induce the production of the intracellular adhesion molecules (ICAMs and 
VCAM-1) on endothelial cells, which bind to adhesion molecules on leukocytes and 
strengthen interactions between leukocytes and endothelial cells, as well as help 
neutrophils and monocytes to enter infected tissue in large numbers to form inflammatory 
foci. As monocytes mature into tissue macrophages and become activated, more and 
more inflammatory cells are attracted into the infected tissue and the inflammatory 
response is maintained and reinforced (76). 
 
NK cells form a lymphocytic subset that express cell surface antigen CD56+. 
They are large granular lymphocytes that develop from bone marrow and circulate in 
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blood before localizing in specific tissues. The cell killing function of NK cells is 
mediated by the release of cytotoxic granules to the surface of bound target cells leading 
to the induction of programmed cell death. NK cells have two types of surface receptors 
to control their cytotoxic activity besides Fas-Fas Ligand mediated cytotoxicity (4). One 
type is an activating receptor (or killer receptor), which triggers killing by NK cells as a 
result of carbohydrate recognition on many cells. In HSV-infected cells, target structures 
for NK cell recognition and induced lysis of infected cells are structural viral 
glycoproteins, nonstructural viral proteins or virally induced cellular gene products 
during the early course of an infection (13) (48). The other type of receptors on NK cells 
are the killer inhibitory receptors, which can inhibit signals induced from activated 
receptors, and thus prevent activation of NK cells. Killer inhibitory receptors are specific 
for MHC (major histocompatibility complex) class I alleles, which help to explain why 
NK cells selectively kill target cells bearing low levels of MHC class I molecules. 
Because altered or absent MHC class I molecules cannot stimulate negative signals, NK 
cells can be activated by activating signals. NK cells are also activated in response to 
many cytokines, such as IFN-#/$ produced by infected cells, dendritic cells or 
macrophage-derived cytokines, e.g., interleukin (IL)-12 and TNF-#. The activated NK 
cells secrete interferon (IFN)-%, which is crucial in controlling infections before T-cells 
have been activated to produce IFN-%. Cytokines with the potential to function in the 
negative regulation of NK cells are IL-10 and transforming growth factor (TGF)-$. IL-10 
produced by Th2 cells can inhibit induction of IL-12 from dendritic cells and 
macrophages, whereas TGF-$ from Th2 cells production can block NK cell proliferation 
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and cytotoxicity as well as inhibit induction of IL-12 and NK cell IFN-% production (12). 
  
Many cytokines produced during innate immune responses, especially the IFN 
families, may dictate host cell susceptibility to virus infection by limiting virus 
replication and spread. There are three categories of interferons: IFN-#, IFN-$ and IFN-% 
(75). The two type I IFNs, IFN-# (leukocyte IFN) and IFN-$ (fibroblast IFN), are 
synthesized by many cell types following infection by viruses and are very different from 
type 2 IFN-% which is produced by CD4+ Th1 cells, CD8 T cells, and NK cells (158). All 
the IFNs share similar signaling pathways that begin with a ligand-receptor interaction, 
followed by activation of tyrosine kinases of the Janus kinase (JAK) family that 
phosphorylates substrate proteins called STATs (signal transducers and activators of 
transcription). These STATs subsequently form homomeric or heteromeric protein 
complexes that translocate to the nucleus and bind to specific DNA sequences in the 
promoter regions of stimulated genes (89). Antiviral activities and immunomodulatory 
actions caused by IFNs provide an early line of defense against specific viral infections. 
The effect of IFNs is to block HSV-1 replication primarily in the early stages of infection 
during the onset of immediate early # mRNA transcription (116). IFNs induced directly 
by virus infection or indirectly via other cytokines, e.g., IL-12, can trigger effective 
cellular defenses including NK cell activity. In addition, they may influence subsequent 
adaptive immune response (12).  
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Other cytokines produced within herpetic lesions in epidermal cells and infiltrating 
immune cells are also critical for the control of virus infection. In herpetic vesicles, high 
concentrations of $-chemokines, IL-12, and IFN-#, $, % are detected (103) (154). The 
local release of $-chemokines at the site of infection recruits monocytes and T-
lymphocytes to the infected tissues. IL-12 activates NK cells and induces differentiation 
of CD4+ T cells into Th1 cells. Macrophages also secret IL-12 and other cytokines, such 
as interferon, IL-1, IL-6, IL-8 and TNF-# within the lesions. CD4+ T lymphocytes may 
secrete a Th1 pattern (IFN-% and TNF-#) or a Th2 pattern (IL-10, TGF-$) of cytokines 
(103). Th1 patterns lead to activation of cytotoxic T cells while Th2 patterns lead to 
production of neutralizing antibodies (33).  
 
 Induction of adaptive immune responses, which includes antigen-specific T and B 
lymphocyte responses, begins with activation of dendritic cells. Dendritic cells are 
potential professional antigen-presenting cells (APCs) residing in most tissue. Dendritic 
cells mature into potent APCs when they take up pathogens, migrate from infected tissue 
in lymph to secondary lymph nodes, from which adaptive immunity is initiated. 
Activated dendritic cells secrete cytokines, such as IFN-#, IL-1#, IL-1$, IL-6, IL-10, IL-
12, TNF-#, and GM-CSF (56), that influence both innate and adaptive immune 
responses. Adaptive immune responses are initiated when naïve T cells in lymph nodes 
recognize antigens on surfaces of dendritic cells and become activated. Naïve T cells then 
mature into effector CD4+ Th1 cells or CD8+ T cells, re-enter circulation and migrate to 
local sites of infection.         
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Inflammatory and neutrophil chemotaxis 
 
Inflammatory. The inflammatory response is part of innate immunity. It occurs when 
tissues are injured by trauma or infection. Chemicals including histamine, bradykinin and 
serotonin are released by damaged tissue. These chemicals cause dilation and increased 
permeability of blood vessels during inflammation, which lead to increase in local blood 
flow and the leakage of fluid that account for the heat, redness, and swelling. TNF-!, IL-
1, and IL-6 are the classical pro-inflammatory cytokines secreted from phagocytic cells. 
Locally, they act together with chemokines to attract inflammatory cells to migrate from 
circulation to the sites of infection and account for the pain. The main inflammatory cell 
types seen in initial phases are neutrophils, which engulf and destroy invading pathogens. 
The influx of neutrophils is followed by monocytes that rapidly differentiate into 
macrophages. Inflammatory responses later in an infection also involve lymphocytes, 
which have meanwhile been activated by antigens that have drained from the site of 
infection via the afferent lymphatics. When the causes of the inflammatory reaction are of 
a high intensity, the production of cytokines is increased, and they are released in the 
circulation provoking the "acute phase response". On the other hand, "inhibitory" 
cytokines, such as IL-10, dampen the activation of some effector functions of T 
lymphocytes and mononuclear phagocytes, by inhibiting the release of pro-inflammatory 
cytokines, thereby turning off the inflammatory processes (27). 
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Neutrophil. Neutrophils are the most abundant white cells in the blood. They were 
historically called microphages due to their smaller sizes compared with macrophages. 
They are also a type of granulocytes, and, together with eosinophil and basophils, are 
called polymorphonuclear leukocytes (PMN) because of their irregularly shaped nuclei. 
Neutrophils are not resident in healthy tissues, but rapidly migrate from blood to the sites 
of tissue damage or infection. The arrival of neutrophils is the first series of inflammatory 
response, by which cells and molecules of innate immunity are recruited into sites of 
infection. Neutrophils themselves release toxic proteases, phagocytize pathogens, and 
generate reactive oxygen intermediates and hydrogen peroxide, promoting the destruction 
of invading pathogens (86). Therefore, they are at the front line of innate immune defense 
to engulf and kill microorganisms. 
 
Neutrophil chemotaxis. Chemotaxis is the process by which cells can detect and migrate 
up a chemoattractant gradient (173). In the initial inflammatory stage, circulating blood 
neutrophils adhere to endothelium in response to proinflammatory factors (e.g. cytokines, 
chemokines, TNF-#, IL-1 and Lipopolysaccharide {LPS}) at the endothelial interface 
and then transmigrate through the vessel wall into tissues by sensing chemoattractant 
gradients secreted from nearby macrophages, mast cells and infected cells. Potent 
neutrophil chemoattractants include bacterial products, such as N-formylated peptides 
(fMLP), host-derived products, such as IL-8, growth-related peptides # (GRO#, GRO-1, 
MGSA, NAP-3, CXCL1), growth-related peptides $ (GRO$, GRO-2, MGSA, MIP-2#, 
CXCL2) and growth-related peptides % (GRO%, GRO-3, MGSA, MIP-2$, CXCL3), 
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epithelial cell-derived neutrophil-activating factor 78 (ENA-78), granulocyte chemotactic 
peptide 2 (GCP2, CKA-3, CXCL6), neutrophil attractant protein 2 (NAP-2, EN-78), 
leukotriene B4 (LTB4), platelet-activating factor, lipoxins; products of immune 
activation, such as complement fragments C3 or C5a (40, 173). Chemokines (such as IL-
8 and LTB4), which allow neutrophils to move to the surrounding areas of infections or 
tissue damage were called intermediary chemoattractants (24). Once neutrophils have 
been attracted to the nearby inflammatory sites, they would then follow a series of end 
target chemoattractants (such as fMLP or C5a) to the final site of infection (64).  
 
Signaling pathways for neutrophil chemotaxis. Neutrophils respond to 
chemoattractants by G protein (heterotrimeric GTP-binding regulatory proteins)-coupled 
receptors on their cell surfaces. Ligation of chemoattractants to these seven-
transmembrane helix receptors triggers the exchange of GTP for the GDP on the # 
subunit of heterotrimeric G proteins and dissociation of # subunit from the $ % subunit 
pair (167). Free G# subunit interacts with phosphatidylinositol-specific phospholipase C 
(PLC), which cleaves phosphatidylinositol-4,5-biphosphate PI(4,5)P2 to generate inositol-
1,4.5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 further mediates the release of 
intracellular Ca+2 from the endoplasmic reticulum and DAG mediates the activation of 
protein kinase C (PKC) (28). Activated PKC subsequently results in neutrophil 
transmigration, including cell adhesion, cytoskeletal reorganization, and actin filament 
polymerization, to push the plasma member forward and induce crawling (90). On the 
other hand, dissociated $% subunit complex of G-protein coupled receptors interact with 
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PI3-kinase, which is responsible for converting member PI(4,5)P2 into PI(3,4,5)P3 (29). 
The accumulation of PI(3,4,5)P3 on the cell membrane determines the leading edge of the 
cell polarity and motility toward chemotactic gradients (159). PI3-kinase also activates 
protein kinase B (PKB or Akt). Upon PI3-kinase activation, PKB (Akt) is recruited to the 
plasma membrane, where it undergoes phosphorylation. The activation of PKB (Akt) 
correlates with the direction of membrane protrusion and the underlying actin 
polymerization (144). The intermediary chemoattractants (IL8 and LTB4) primarily 
function via this PI3K/Akt pathway after they interact with G protein coupled receptor on 
the cell surface. End target chemoattractants (fMLP and C5a), however, function 
primarily by dissociated G$% subunit complex activating PI3K% leading to p38 mitogen-
activated protein kinase (MAPK) activation (64).  
 
 Besides the classical G-protein receptor-coupled signaling pathways described 
above, neutrophil chemotaxis can also be mediated by protein tyrosine kinases (PTKs). 
However, the steps that follow the activation of the G protein-coupled receptors and link 
them to the modulation of the activity of tyrosine kinases remain unclear. Among more 
than 10 subfamilies of PTKs, several PTKs involved in neutrophil transmigration 
signaling transduction have been identified, including Fgr, Hck, Lyn, Yes and Syk (163) 
(128) (107). Other PTK, such as Tec family tyrosine kinases, Btk, Tec and Bmx, are also 
involved in the regulation of neutrophil transmigration (82).  
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Innate immunity signaling pathways 
 
It is unclear if B virus induces cellular signaling pathways to regulate these host 
innate immune responses, but studies using HSV-1-infected cells have demonstrated that 
several cellular signaling pathways are up-regulated to activate transcription factors that 
ultimately coordinate immune responsive gene expression during the course of HSV-1 
infection (Table 1). Based on experimental evidence, some investigators suggest that 
HSV-1 utilizes glycoprotein D (gD) binding to the HveA receptor to activate the 
transcription factors NF-!B (nuclear factor of kappa light polypeptide gene enhancer in B 
cells) and AP-1 (activator protein 1, c-Jun, p39) (93) (108) (3) (83) (98). The activation 
of NF-!B by HSV-1 can also depend on virus penetration and/or immediate early gene 
expression of ICP4 (Infected Cell Protein 4) and ICP27 (122) (2). Other cellular signaling 
pathways by which HSV-1 can induce transcription factors AP-1 and ATF-2 (activating 
transcription factor-2) involve ICP0 and/or VP16 (Virion Polypeptide 16) to activate 
MAPK family, Jun N-terminal kinase (JNK) and p38 pathways (77) (174) (97). 
Additionally, the activation of MAPK pathway can be potentially dependent on HSV-1 
glycoprotein H (gH) binding to induce JNK activity (52).  
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Table1: HSV induced signal transduction pathway review. 
 
Virus Cell line Viral gene Signaling 
pathway 
Induced 
cytokine 
Reference 
HSV-1 RAW264.7 
(murine 
macrophage) 
NIH3T3 
(murine 
fibroblast) 
 
ICP0 
 
PKR 
NF-!B 
IRF3 
 
RANTES/CCL5 
(99) (100)  
HSV-1 Human 
PBMC 
gD  IFN-# (3)  
HSV-1 Human 
PBMC 
gD  IFN-# (62)  
HSV-1 RAW264.7 gD 
Early post-
entry event 
dsRNA-PKR 
 TNF-# (within 
2-24 h) 
(103)  
HSV-2 RAW264.7 
C57BL6/ 
peritoneal 
cells 
gD NF-!B 
ATF2/Jun 
(transcriptional 
regulation) (1h 
p.i.) 
AU-ruch 
region of 3’ 
untranslated 
region 
(translational 
regulation) 
TNF-# (100, 121)  
HSV-2 Murine 
macrophage 
  IFN-#/$ 
TNF-# 
 
(26)  
HSV-1 Purified DC 
from human 
PBMC 
  IFN-#, IL-1#, 
IL-1$, IL-6, IL-
10, IL-12, GM-
CSF, and TNF-# 
within 4 to 12 h 
IFN-# and IL-6 
within 24 h 
 
 
 
 
(44, 56) 
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Virus Cell line Viral gene Signaling 
pathway 
Induced 
cytokine 
Reference 
HSV-1 C57BL/6Cr 
Corneas and 
TG 
  IL-1#, IL-5, IL-
6, IFN-% (2-7 
days p.i.) 
 
(48)  
HSV-2 BALB/c   IL13 
 
(101)  
 HSE-1 
(Herpes 
simplex 
encephalitis 
type I) 
patient CSF 
and serum 
  IL-8, 
macrophage 
inflammatory 
protein 1 (MIP-
1), monocyte 
chemoattractant 
protein 1 (MCP-
1), and 
RANTES 
 
(119, 132)  
HSV-1 EMT-6 
(permissive 
murine 
epithelial-
like cell line) 
ICP0, ICP4, 
ICP8, ICP27 
independent 
 
Viral 
replication 
dependent 
NF-!B. 
Increased 
levels of 
MyD116, 
GADD34 
IL-6.  
IL-1, IL-7, IL-10 
(2-12 h) 
(60)  
 
HSV-2 J774A.1 
(murine 
macrophage 
cell line) 
 Viral 
replication 
dep. 
NF-!B 
IL-12 (63)  
HSV-1 
HSV-2 
Human 
PBMC 
Murine 
peritoneal 
cells,  
J774A.1, 
RAW264.7 
ICP0, ICP4, 
ICP27  
independent, 
dsRNA 
PKR 
NF-!B 
p38 dependent 
 
IL-6 (99)  
HSV Human 
vesicle fluid 
  High IL-1$,  
IL-6, MIP-1$ 
moderate IL-1#, 
IL10, low IL-12 
(day 1) 
(89)  
HSV-1 Vero gH JNK  (52)  
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Virus Cell line Viral gene Signaling 
pathway 
Induced 
cytokine 
Reference 
HSV-1 
HSV-2 
Human adult 
and newborn 
keratinocytes 
72 h p.i.  IFN (120)  
U.V. 
HSV-1 
Mice 
deficient 
IFN$ and 
IFNAR 
2, 4, 6 h p.i.  IFN-# (7)  
U.V. 
HSV-1 
Mice 
mononuclear 
leukocytes 
3-9 h  IFN-#/$ (31)  
 
 
Innate immunity and NF-!B  
 
Overview. Innate immunity is the first line of the host defense system against invading 
pathogens. The main players in innate immunity are the phagocytes, such as 
macrophages, neutrophils, and dendritic cells. These cells recognize invading pathogens 
by germ-line-encoded pattern recognition receptors (PRRs), which are mainly dependent 
on the Toll-like receptors (TLRs) family. The engagement of TLRs with microbial 
products activates and initiates several intracellular signal transduction pathways, such as 
NF-!B, JNK (MAP Kinase) (152). The activation of NF-!B is one of the most prominent 
and best characterized signal transduction pathways. When TLRs bind with their ligands, 
TLRs subsequently recruit adapter MyD88 and interact with MyD88 via a homotypic 
TIR (Toll/IL1-receptor homologous region) connection. The death domain of MyD88 
then recruits IRAK (IL1 receptor-associated kinase) to the receptor complex. IRAK is 
then autophosphorylated and dissociated from the receptor complex and recruits TRAF6 
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(TNF receptor associated factor 6), which in turn activates downstream kinases such as 
NIK or MEKK1. Activated NIK or MEKK1 is individually capable of activating the I!B 
kinase (IKK) complex. Ultimately, the I!B# subunit is phosphorylated and degraded, 
releasing NF-!B, leading to nuclear translocation of NF-!B and modulation of target 
genes transcription. 
 
 NF-!B regulates the expression of a variety of genes that play important roles in 
innate immunity. These NF-!B target genes include those encoding cytokines (e.g.IL-1$, 
TNF-#, TNF-$, IL-2, M-CSF, GM-CSF, G-CSF, IFN-$, IFN-%, IL-6, proenkephalin, 
TGF-$2), chemokines (CCL2, CCL3, CCL5, CXCL1, CXCL2, CXCL3, CXCL8, 
CXCL10), adhesion molecules (ELAM-1, VCAM-1, ICAM-1), acute phase proteins 
(angiotensinogen, serum amyloid A precursor, complement factor B, complement factor 
C4, urokinase-type plasminogen activator), and inducible enzymes (NO-synthetase, 
cyclooxygenase-2, perforin) (147). Which of these genes is modulated is dependent on 
which components of NF-!B complex bind to specific genes or transcription promoter 
complexes. 
 
NF-!B background. NF-!B was first described in 1986 as a nuclear factor necessary for 
immunoglobulin k light chain transcription in B cells (57). Since it was first observed, 
NF-!B has been found to play a role in immune responses, apoptosis, cell growth control 
and development.   
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The NF-!B protein family. All NF-!B proteins contain a conserved N-terminal region, 
called the Rel Homology Domain (RHD) (about 300 amino acids in length). The N-
terminal part of the RHD contains the DNA-binding domain, whereas the dimerization 
domain is located in the C-terminal region of the RHD. Close to the C-terminal end of the 
RHD is the NLS (Nuclear Localization Signal), which is essential for the transport of 
active NF-!B complexes into the nucleus. NF-!B proteins can be grouped into two 
classes: one includes the p105 and p100, which are precursor proteins to p50 (NF-!B1) 
and p52 (NF-!B2) protein, respectively, and the other class includes Rel (c-Rel), v-Rel, 
RelA (p65) and RelB protein (147). Only RelA (p65), RelB and c-Rel contain potent 
Transactivation Domains (TDs) within sequences in RHD C-terminal domains. The TDs 
consist of abundant serine, acidic and hydrophobic amino acids that are essential for 
transactivation activity. In contrast, p50 and p52 do not possess TDs, and therefore 
cannot act as transcriptional activators by themselves. The molecular structure of NF-!B 
is composed of various combination of NF-!B family polypeptides in a homo- or hetero-
dimer forms. The p50/p65 complex is present in essentially all cells, and is usually the 
most abundant dimeric complex. Some of dimeric forms like p65/p65 or Rel/Rel or 
p65/Rel are present at very low levels, but play important roles on specific promoters. 
The members of the Rel/NF-!B family can form almost all theoretically possible homo- 
and hetero-dimers, but complexes that have never been detected are RelB/RelB, 
RelB/RelA, and RelB/Rel. The various dimeric complexes differ in their preference for 
certain !B sites, transactivation potentials, kinetics of nuclear translocation and levels of 
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expression in tissue. The p50/p65 tends to be rapidly translocated to the nucleus in 
response to extracellular stimulations (147). 
Nuclear/cytoplasmic status of NF-!B forms. NF-!B normally resides in the cytoplasm 
and its NH2-terminal region, RHD, is bound by an inhibitory protein complex I!B, an 
inhibitor of NF-kB. Phosphorylation of I!B# by I!B kinase (IKK) results in the release 
of NF-!B, which then moves into the nucleus where it binds to cis-acting !B sites (5’-
GGRNNYYCC-3’) (R: purine, Y: pyrimdine) in promoters and enhancers of over 100 
regulatory genes involved in inflammatory and chemotaxic cytokines, stress responses, 
apoptosis, growth factors, and transcription factors (6). Although NF-!B generally 
interacts with I!B in the cytoplasm of most cell types and translocates to the nucleus 
upon stimulation with many stimuli (e.g., cytokines, mitogens, physical stress, oxidative 
stress, chemical agent, parasite, bacteria and bacterial products, viruses and viral 
products), the ubiquitous p50/p50, p52/p52 homodimer or p50/p52 localizes largely to 
nuclei in unstimulated cells. The role of this factor in constitutive-type transcription is 
unclear, but it may serve as a transcription repressor and protect some genes from 
modulation by other forms of NF-!B transactivating factors (147).  
 
The I!B (inhibitor of kappa light polypeptide gene enhancer in B cells) protein 
family. In mammals, the I!B family proteins include I!B#, I!B$, I!B%, I!B&, I!B", 
BCL3 (B-cell CLL/lymphoma 3) and the precursor Rel-proteins, p100 and p105. All 
members of the family share a partially conserved domain that harbors between six to 
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eight ankyrin motifs, each 33-amino acids in length (14) (114). These ankyrin motifs 
interact with the nuclear localization signal (NLS) located at the end of the RHD domain 
of NF-!B to interfere with NF-!B nuclear translocation and inhibit DNA binding of 
REl/NF-!B complex (9) (53) (65). All of the I!B members act in the cytoplasm, except 
I!B" and BCL3, which are thought to act in the nuclei. Various members of the I!B 
family target different NF-!B complexes, e.g, I!B# and I!B$ interact preferentially with 
p65/p50 and c-Rel/p50, I!B& binds only to p65 and c-Rel hetero-and homodimers (153) 
(165), I!B" binds to p50 subunit of p65/p50 and p50/p50(171) and BCL-3 associates 
exclusively with p50/p50 or p52/p52 (115). Due to the functional difference of each I!B 
family member, the transcription factor NF-!B can be regulated differentially by I!B 
subunits. For instance, I!B# is rapidly degraded upon phosphorylation, which leads to an 
immediate, but transient activation of NF-!B; I!B$ is slowly degraded, but is associated 
with a more sustained activation of NF-!B (6); I!B& regulates late, transient activation of 
NF-!B complexes (165); I!B" is not rapidly degraded, but stably accumulates in the 
nucleus where it inhibits NF-!B activity or plays a direct role in transcriptional activation 
(155) (169); BCL-3 can displace inhibitory p50/p50 from DNA and free I! binding sites 
for interaction with other NF-!B forms (50), whereas the ternary complex of BCL-3 and 
p52/52 induces the transcription of the NF-!B target gene (cyclin D1) (49) (164) (130).  
 
I!B" . Three I!B" variants have been found to date, transcript variants 1, 2 and 3. (80) 
(171) (155). Both transcript variants 1 and 2 were cloned from murine macrophage-like 
cell line RAW264.7, and their protein products were found to be localized in the nucleus 
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where they preferentially bind to NF-!B p50. The longer form, transcript variant 1 or 
I!B" (L) or MAIL-L, is predominantly induced upon LPS stimulation (170). The shorter 
form, transcript variant 2 or I!B" (S) or MAIL-S differs in the 5' UTR and coding region 
compared to variant 1 (171). The resulting I!B" (S) is 99 amino acids shorter at the N-
terminus compared to I!B" (L). The transcript variant 3 was cloned from human cell 
lines and lacked exon 2 (nt-193-268) (155). All three forms of I!B" harbor 6 ankyrin-
repeats in the carboxyl-terminal region, similar to what is observed in other I!B proteins. 
Interestingly, the amino-terminal regions of these molecules exhibit no significant 
homology to any other known proteins.  
 
In contrast to the typical cytosolic and constitutively expressed I!B proteins, I!B" 
is localized in the nucleus, where it binds preferentially to the NF-!B p50 subunit, rather 
than the p65 subunit, without prevention of their nuclear translocation. In vitro 
experiments have demonstrated that the carboxyl-terminal domain with the ankyrin-
repeats blocks DNA binding of p65·p50 heterodimers as well as p50 homodimers (171). 
Overexpression of I!B", however, results in augmentation of IL-6 expression in response 
to LPS, but inhibits TNF-# expression (112). These data suggest that I!B" is a key 
regulator of NF-!B and exhibits dual positive and negative functions that is target gene 
specific. 
 
Mutual regulation of NF-!B and I!B" . I!B" is hardly detectable in unstimulated cells, 
but is strongly induced by LPS, IL1 or other pathogen components through Toll-like 
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receptor. NF-!B activation is essential, but not sufficient for the induction of I!B" (171) 
(46) (169) (155). I!B" induction requires both NF-!B activation and stimulus-specific 
stabilization of its mRNA (170). 
 
Mutual regulation of NF-!B and I!B#. The activity of NF-!B is usually tightly 
regulated in normal cells. Upon activation of NF-!B, cytoplasmic I!B# is 
phosphorylated and degraded.  I!B# mRNA and protein are also induced about 20 min 
after the initial signaling (19) (150) (142) (38). This feedback inhibition presumably is 
destined to restore the inhibited NF-!B state and to control the NF-!B regulated genes 
whose functions can be harmful to the cells.   
 
Induced synthesis of NF-!B. The precursor proteins p105 and p100 are induced after 
cellular stimulation with agents that also activate NF-!B (17) (16). Induced expression of 
the NF-!B precursors presumably replenishes NF-!B in the cytoplasm after NF-!B is 
translocated into the nucleus. These precursors may also be critical for limiting activation 
and retaining any newly synthesized NF-!B protein like RelB or cRel in the cytoplasm, 
either which may be imported once I!B is degraded in response to stimuli. In addition to 
p100 and p105, Rel and RelB are also found to be transiently upregulated in response to 
stimuli that activate NF-!B(22) (134). The expression of RelA, however, is essentially 
constitutive and only small increases, if any, have been noted following various cellular 
stimulations (109). Induction of NF-!B subunits may be necessary to sustain nuclear NF-
!B activity over longer periods of stimulations. 
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NF-!B signaling pathway: activation of NF-!B activity. NF-!B is activated to 
translocate into the nucleus in response to numerous stimuli that include cytokines (TNF-
#, TNF-$, IL-1#, IL-1$, LIF, IFN-%, M-CSF, GM-CSF), mitogens (antigen, allogeneic 
stimulation, lectins, phorbol esters, diacylglycerol), bacteria and bacterial products (LPS, 
toxins), viruses (CMV, HIV-1, HSV-1, HHV-6, Newcastle disease virus, Sendai virus, 
Adenovirus 5) and viral products (dsRNA, HTLV-1 Tax, HBV Hbx, EBV EBNA-
2/LMP), parasite, physical stress (UV light, ionizing radiation), oxidative stress 
(Hydrogen peroxide, Butyl peroxide) and chemical agents (Ceramide, Calyculin A, 
Cycloheximide) (118) (94). Following exposure of a cell to an inducer, NF-!B-inducing 
kinase (NIK) or mitogen-activated protein kinase/ERK kinase kinase (MEKK) is 
activated and I!B kinase (IKK) complex is phosphorylated. IKK complex, which is 
comprised of phosphorylated IKK#, phosphorylated IKK$ catalytic subunits, and IKK% 
regulatory subunit, targets I!B and results in I!B subunit phosphorylation (58). 
Phosphorylated I!B subunits are then recognized by the $-TrCP-containing SCF 
ubiquitin ligase complex, resulting in ubiquitination of the subunit and degradation by the 
26S proteasome (141). The degradation of I!B subunits exposes the nuclear localization 
signal of the previously complexed NF-!B protein.  NF-!B then translocates from 
cytoplasm to the nucleus where it binds to enhancers or promoters of target genes (148), 
unless it is retained in the cytoplasm by other mechanisms.  In this canonical pathway, 
IKK$, but not IKK#, is essential for inducible I!B subunit phosphorylation and 
subsequent degradation. 
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 A second, evolutionarily conserved NF-!B pathway is strictly dependent on 
IKK#, but independent of IKK$ and IKK% (143). In this pathway, TNF-cytokine family, 
but not TNF-#, activates NIK, which targets IKK#. Phosphorylated IKK# results in the 
phosphorylation of p100/RelB and subsequent p100 processing to p52 by an 
ubiquitinated-dependent cleavage. The p52/RelB dimer is then translocated into the 
nucleus. This alternative NK-!B activation pathway is only involved in adaptive 
immunity, which is required for B cell maturation and formation of secondary lymphoid 
organs.  The classical NF-!B pathway, however, is mostly observed in innate immunity. 
Although it is clear that many different inducers initiate NF-!B signal transduction 
pathways as described above, several kinases, e.g., double-stranded RNA activated 
kinase (PKR) (81), Raf-1 protein kinase (88), PKC" (42), and nuclear factor kappaB 
kinase (61), have also been implicated in the phosphorylation of I!B subunits, which is 
then followed by activation of NF-!B. 
 
HSV-1 and NF-!B. It has been documented that HSV-1 activates NF-!B in C33 cells 
(human epithelial cells), U2-OS cells (human epithelial cells), and primary human 
fibroblasts (68) (122). NF-!B activation occurs in a biphasic manner (122) (59). The 
initial activation occurs very rapidly (within 30-45 min) and in a transient manner, and 
has been suggested to be related to a gD-receptor interaction (98). The second activation 
is delayed (within 3 and 4 hours), robust and sustained, and is dependent on virus entry 
and de novo ICP4 and ICP27 synthesis and turnover of I!B# and I!B$ (122) (2). The 
function for NF-!B activation by HSV-1 is to enhance the efficiency of virus replication 
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(122) and induce the expression of proinflammatory cytokines, interferons (87) (121) 
(99).  
 
 In summary, NF-!B has been shown to play as a central coordinator in the 
induction of a variety of genes critical for immune and inflammatory responses. Research 
has tended to focus on NF-!B signaling in the effector functions of hematopoietic 
components of the immune system, and its role has been well established in innate 
responses to all classes of pathogen. In addition, there is now increasing evidence to 
support a broader model in which NF-!B also supports the resolution of inflammatory 
responses, and initiation the coordination of the adaptive immune response. Yet, the exact 
molecular mechanism and interactions between upstream and downstream molecules in 
NF-!B signaling pathway can be pathogen- or cell type-specific. The characterization of 
the biochemical events leading to NF-!B activation is still a major challenge. However, 
understanding the molecular details involved in the regulation of NF-!B activity will 
allow us to modulate this pathway to control human diseases that originate by infections.  
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Part 2. Research Goals 
 
 B virus is one of the most feared occupational health hazards in the biomedical 
research community that depends on macaque monkeys or cells/tissues derived from 
these animals for research advances.  Zoonotically infected humans can succumb to B 
virus infection within weeks to years post exposure, but infected macaques show little-to-
no sign of infection. From observations made from human infections, it is known that B 
virus can invade the CNS very quickly. The infection tends to localize to the brainstem, 
causing disruption of autonomic functions including respiration, eventually resulting in 
death. During this time, the adaptive immunity against B virus is either not generated or 
not effective. Therefore, we hypothesize that B virus infection in human cells is 
associated with defective induction of the innate immune response. This hypothesis is 
also based on clinical observations of HSV-1 and HSV-2, as well as other herpesvirus 
infection outcomes in the presence and absence of innate immune responses. This 
hypothesis can be examined only partially since definitive, controlled infections in the 
humans can never be done. Studies proposed herein, however, will allow examination of 
early host responses that occur within target infected cells. To test the hypothesis, the 
following specific aims were designed:  
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1. develop a human cell culture model to identify early host responses to B virus 
infection;  
2. identify virus-mediated human host cell responses at early time points of 
infection that  target immune cell functions; 
3. design and test blocking strategies to determine whether modulation of early 
events in the initially infected cell can alter immune response outcomes observed 
and described. 
 
 Experiments to accomplish each specific aim will distinguish infection-related 
events that may result in the observed outcomes of B virus infection in human hosts. 
Examination of the observed sequence of events in human cells will identify potential 
targets that can be utilized to modulate infection-related events in zoonotically infected 
humans.  
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SECTION II: MATERIALS AND METHODS 
 
Cells and viruses 
 Monolayers of human foreskin fibroblast (HFF) (ATCC, CRL-2097) cells were 
grown in Eagle’s minimum essential medium (Mediatech, Herndon, VA) supplemented 
with 0.1 mM non-essential amino acids, 1.0 mM sodium pyruvate, and 10% fetal bovine 
serum (FBS). B virus laboratory strain E2490 and HSV-1 MacIntyre (ATCC, VR-539) 
were propagated in Vero cells (ATCC, CL81). All infections with B virus were 
performed under strict BSL-4 conditions in accordance with the Biosafety in 
Microbiological and Biomedical Laboratories (BMBL, 4th edition) manual (157). This 
laboratory is a registered facility for handling B virus under the Select Agent status.  
 
Growth kinetics of viruses  
 The plating efficiency of viruses on Vero and HFFs were performed by 10-fold 
serial dilution of virus stocks and plated onto cells in 6-well plates. Virus titer was 
determined by counting plaque formation 2 days p.i. after crystal violet staining. To 
quantify the expression levels of viral genes, PCR primer sequences there were conserved 
in both B virus and HSV-1 were used to amply ICP0 (5’-CTCGAGCGTGGTGGCCAT-
3’ and 5’-GGGTCATCCAGAGGCCGT-3’) and TK (5’-TGGACCTGGCCATGCTGTC 
and CAGCAGGTCGAGCGTCCAC-3’) gene. The PCR cycle used was as followed: 
95°C for 15 min, 35 cycles of 95°C for 30 sec, 65°C for 30 sec, and 72°C for 10 min for 
one cycle. PCR products were quantified by running 1.5 % agarose gels after ethidium 
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bromide staining and analyzed by Kodak 1D Image analysis software. PCR band 
intensities were normalized to the band intensity of the control gene, $-actin. 
 
Microarray and data analysis 
Replicate cultures of HFF cells were mock-infected or infected with B virus 
(E2490) or HSV-1 (MacIntyre) at a multiplicity of infection (m.o.i.) of 10 at 4°C for 1 h, 
a time point designated as 1 h post infection (p.i.). Virus inoculum was removed after 1 h 
p.i., and the incubation temperature was then shifted to 37°C.  Total cellular RNA 
isolated at 1, 3 and 5 h p.i. was used to generate cRNA for DNA microarray analysis 
using HG-U133 A/B gene chips (Affymetrix, Santa Clara, CA). Microarrays were 
performed according to manufacturer’s instructions. Chip hybridization results were 
quantified using the GeneArray Scanner and GeneChip Operating Software 1.4 
(Affymetrix, Santa Clara, CA). Microarray data was deposited into the National Center 
for Biotechnology Information (NCBI)'s Gene Expression Omnibus (GEO) repository 
under the assigned accession number GSE4521.  
 Resulting microarray image files were analyzed using the R-Bioconducting 
package (http://www.bioconductor.org) analysis. The hybridization intensity of each 
probe was generated by running affy package, which processed an image of the 
microarray (stored in a .DAT file) to produce a .CEL file to contain signal intensity of 
each probe on the array. To normalize data, Robust Multichip Analysis (RMA) algorithm 
was used (15). Normalized data were analyzed by False Discovery Rate (FDR) (q cut-off 
value <0.002) and two-factor analysis of variance  (ANOVA) (p cut-off value < 0.003). 
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Data were also imported into GeneSpring GX v7.2 (Silicon Genetics, Redwood City, 
CA) to perform hierarchical gene clustering (gene tree) across different time points post 
infection. To calculate the gene expression level, the average normalized expression level 
of a given gene per condition was compared to the mean of all normalized gene 
expression levels across all genes. Any genes having ratios greater or equal to 1.0 were 
defined as up-regulated genes; and ratios having less than 1.0 as down-regulated genes. 
Mock-infected samples were also compared for normalization of comparative data 
exploring differences between B virus and HSV-1. 
 
Biological function and network analysis 
A total of 1000 genes with greatest-fold changes that passed FDR, q cut-off 
values < 0.002 and ANOVA p cut-off values < 0.003 from each time point were analyzed 
for their biological functions and networks by the Ingenuity pathway analysis software 
(Ingenuity, Redwood city, CA). Global functional analysis was used to specify the 
significance of how likely it was that genes from the dataset file under investigation 
participate in that function. The significance for each function was expressed as the 
negative exponent of the Fischer’s exact test p-value, which was calculated by comparing 
the number of user-specified genes of interest that participate in a given function relative 
to the total number of occurrences of these genes in all functional annotations stored in 
the Ingenuity Pathways Knowledge Base. For biological network generation, imported 
genes that were mapped to their corresponding gene objects in the Ingenuity pathways 
knowledge base, called focus genes, were overlaid onto a global molecular network. The 
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likelihood of the focus genes in a network being found together due to random chance 
was displayed as the score. For example, a score of 2 indicated that there was a 1 in 100 
chance that the focus genes were found together in a network due to random chance. 
Therefore, scores of 2 or higher had at least a 99% confidence of not being generated by 
random chance alone. In this study, a score ' 45 was used as the cut-off value to select 
for highly significant biological networks regulated by B virus and HSV-1.  
 
Real-time RT-PCR 
Total RNA was extracted from mock- and virus-infected cells at 1, 3, and 5 h p.i. 
using QIAGEN’s RNeasy Total RNA Isolation kit (Qiagen, Valencia, CA) according to 
the manufacturer's instructions. Reverse transcription reactions were performed on 2 µg 
of total RNA using an oligo dT primer (Promega, Madison, WI) with SuperScript II 
(GIBCO BRL, Carlsbad, CA). Real-time PCR reactions were performed in a 30µl 
volume that included dilute cDNA sample, primers (1µg/ml), probe and TaqMan 
Universal PCR Mater Mix (Applied Biosystems, Foster City, CA) by using Applied 
Biosystems Prism 7900-HT sequence detection systems. Primers and probes used were 
designed by Primer Express v1.5 (Applied Biosystems, Foster City, CA). To compare 
mock- and virus-infected cell samples, relative changes in gene expression were 
determined by using the relative standard curve method for quantification according to 
the manufacturer's instructions. To calculate the fold-change ratio comparing virus 
infected to uninfected samples, genes having ratios greater or equal to 1.0 were defined as 
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up-regulated genes; and ratios having less than 1.0 as down-regulated genes. These fold 
changes were quantified more precisely with quantitative RT-PCR.   
 
Isolation of neutrophils 
Human blood was anticoagulated with 3.8% sodium citrate (use 6 ml of 3.8% 
sodium citrate for every 54 ml blood).  Blood samples were centrifuged at 400 x g for 10 
min at 4°C to remove platelet-rich plasma supernatant. The leukocyte-rich fraction 
containing red blood cells were separated by adding cold 2% dextran (in 0.9% sodium 
chloride) to total volume of 50 ml. Red blood cells was sedimented under gravity for 35 
min at 4°C, and the leukocyte-containing top fraction was collected and centrifuged at 
400 x g for 10 min at 4°C. The resulting leukocyte-enriched pellet was resuspended in 10 
ml of cold 0.9% NaCl and then layered over onto the top of 3 ml of cold ficoll-paque (GE 
Healthcare Bioscience AB, Piscataway, NJ). After centrifugation at 400 x g for 30 min at 
4°C, neutrophils were found in the pellet. The neutrophil-rich pellets were collected; 
contaminating red blood cells were removed by adding cold hypotonic lysis buffer (155 
mM NH4Cl, 2 mM NaHCO3, 0.1 mM EDTA).  Neutrophils were then washed once with 
cold Hanks balanced salt solution (HBSS) without calcium and magnesium.  Cells were 
resuspended at a density of 5x107 cells/ml in cold HBSS and remained viable suspended 
in HBSS for about 4 hours at 4°C.  
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Neutrophil transmigration assay 
HFF cells prepared in T-150 flasks were either mock infected or exposed to B 
virus or HSV-1 at m.o.i. of 10. At time points 1, 2, 3, 4, 5 and 6 h p.i., collected culture 
fluids were centrifuged at 400 x g for 10 min and the supernatants were frozen at -80°C 
for subsequent assays.  
Neutrophil transmigration assays were performed by adding freshly isolated PMN 
(1×106 cells in 150 µl HBSS) to the upper chamber of the transwell setups separated 
from the bottom chamber by a collagen coated 5 µm pore size polycarbonate filter with a 
surface area of 0.33 cm2 (Costar, Cambridge, MA). The transwells were coated with 
collagen (purified from rat-tails, 50ug/ml in 70% ethanol) and dried in a hood overnight 
before use. On the bottom chamber, 0.5 ml of tested samples contained (1) fresh medium 
(negative control) (2) medium plus 0.1µM fMet-Leu-Phe or 0.4µg/ml IL-8 (positive 
control) (3) supernatants from mock-infected cells (4) supernatants from HSV-1 infected 
cells were added in triplicate wells. The assembled chambers were incubated at 37 °C for 
1 h to 3 h and neutrophils migrating into the lower chamber were quantified by 
solubilizing neutrophils with 1% Triton X-100 and assaying for  myeloperoxidase (MPO) 
activity by measuring optical density units (OD) at A405 after adding substrate ABTS 
(2,2′-Azino-bis-3-ethylbenzthiazoline-6-sulfonic acid). The percentage of cells 
transmigrating across the transwell filter was calculated by a standard curve method, 
which was constructed by serial diluting cell numbers (10-fold serial dilution of 1×106 
cells) versus their OD405 values. Student’s t-test was used to compare the chemotactic 
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activity between supernatants from virus- and mock-infected cells and a p value of <0.05 
was considered to be a significant change. 
  
Virus infected cell supernatant-mediated inhibition of neutrophil transmigration  
Neutrophils were isolated as described above. In the transwell setups, 1x106 
neutrophils were added to the upper chamber. The neutrophil transmigration inducers, 0.2 
µM f-MLP or 200 ng/ml IL-8, were added into the lower chamber of the transwells 
setups in addition to the presence of 0.5 ml tested mocked-, or B virus- or HSV-1-
infected cell supernatants. Neutrophil transmigration was initiated by incubation at 37°C 
and neutrophil migration into the f-MLP or IL-8-containing lower chambers was 
quantified by MPO activity measurement as described above. 
  
ELISA (enzyme-linked immunosorbent assay) for detection of IL-8 
HFF cells prepared in T-150 flasks were either mock infected or infected with B 
virus or HSV-1 at m.o.i. of 10 at 4°C for 1 hour. This time point was designated as 1 h 
post infection. Inocula were then replaced with fresh medium and cells were incubated at 
37°C/5%CO2. At 2, 3, 4, 5 and 6 h time points p.i., culture fluids were collected and 
stored at -80°C for the subsequent IL-8 ELISA assay (RDI, Concord, MA) according to 
the manufacturer's instructions. 
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Quantification of NF-!B p50 nuclear translocation 
HFF cells plated into 96 well microplates (Costar, Coming, NY) at 2x104 cells per  
well were incubated with B virus at m.o.i. of 10 for 1, 2, 3, 4, 5, and 6 h p.i. HFF cells 
treated with TNF-# (0.1µg/ml) for 1 h were used as a positive control. Cells were fixed in 
4% formaldehyde for 15 min after infection, permeabilized in 0.2% Triton X-100 for 10 
min, and then washed with phosphate buffer saline (PBS). The nuclei were stained with 
Hoechst 33342 (Molecular probes Inc., Eugene, OR) for 15 min at room temperature. 
After washing slides with PBS three times, slides were treated with blocking solution 
(1% bovine serum albumin in PBS) at 37°C for 1 h. Immunofluorescent staining was 
performed by incubating slides with rabbit anti-NF-!B p50 (1:100) antibody at room 
temperature for 1 h, followed by incubation with fluorescein conjugated goat anti-rabbit 
IgG (1:200). Cells were then washed, sealed and stored at 4°C until they were scanned on 
an ArrayScan HCS Reader (Cellomics, Pittsburgh, PA), with the Cytoplasm to Nucleus 
Translocation BioApplication, using a 20x objective. The activation of NF-!B p50 was 
analyzed by measurement of the amounts of NF-!B p50 translocation from the cytoplasm 
to nucleus and represented as the difference in average fluorescent staining intensity 
between the nucleus and cytoplasm. 
 
Preparation of nuclear extracts 
HFF cells in T-150 flasks were mock-infected or exposed to B virus or HSV-1 at 
m.o.i. of 10 and harvested at 1, 2, 3, 4, 5, and 6 h p.i. Before harvesting cells, cells were 
washed twice with cold PBS. Cells were scraped into 10 ml cold PBS and centrifuged at 
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1500 x g for 5 min. Cell pellets were suspended in 10 ml of hypotonic 0.1 M Tris-Cl, 
0.01 M NaCl, and 0.0015 M MgCl2 (TSM) and stored on ice for 30 min. Swollen cells 
were homogenized with 100 strokes in a cold Teflon: glass Potter-Elvehjem 
homogenizer. The homogenate was then mixed with 1ml of Triton X-100 (20% w/w) to a 
final concentration of 1.8%. Nuclei, recovered by centrifugation at 1000 x g for 10 min, 
were suspended in 50 µl buffer C (20 mM HEPES, pH 7.9, 0.4 N NaCl, 1 mM EDTA, 1 
mM EGTA, 1 mM DTT, 1 mM PMSF), and the tube was vigorously rocked at 4°C for 25 
min on a shaking platform. The nuclear extracts were centrifuged at 20,000 x g for 5 min 
at 4°C and the supernatant was frozen in aliquots at –70°C. Protein concentrations were 
determined by Coomassie Plus Protein Assay Reagent Kit (Pierce, Rockford, IL). All 
further manipulations of inactivated B virus infected materials were done in BSL-3.  
 
NF-!B p50 DNA binding activity assay 
NF-!B p50 DNA binding activity assay was performed by an ELISA-based 
TransBinding NF-!B p50 Assay Kit (Panomics, Redwood City, CA) according to 
manufacturer’s instructions. In this kit, an oligonucleotide containing a NF-!B consensus 
binding site was immobilized on the 96-well plate. Activated NF-!B p50 from 10 µg 
nuclear extracts specifically bound to this oligonucleotide was detected by antibody 
directed against the p50 subunit. An additional secondary horseradish peroxidase (HRP)-
conjugated antibody provided a colorimetric optical density readout by 
spectrophotometry (A450). 
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Immunofluorescent staining 
 HFF cells in 16-well chamber slides were infected with B virus or HSV-1 at 
m.o.i. of 10 for 1, 2, 3, 4, 5 and 6 h. Cells were fixed in 3.7% formaldehyde for 15 min 
after infection, permeabilized in 0.2% Triton X-100 for 10 min, and then washed with 
phosphate buffer saline (PBS). Nuclei were stained with Hoechst 33342 (Molecular 
probes Inc. Eugene, OR) and F-actin was stained with Alexa Fluor 568 phalloidin 
(Molecular probes Inc. Eugene, OR). Cells were then stained with the primary antibodies 
rabbit anti-I!B" IgG (Imgenex, San Diego, CA) and rabbit anti-NF!B p50 IgG (Santa 
Cruz Biotechnology Inc. Santa Cruz, CA) (H-119) at room temperature for 1 hour, 
followed by incubation with fluorescein conjugated secondary antibody goat anti-rabbit 
IgG. Slides were mounted by VECTASHIELD (Vector Laboratories) and were observed 
with a Zeiss LSM 510 confocal laser scanning microscopy.  
 
Knockdown I!B"  by siRNA 
The siRNA duplexes, MAIL siGENOME SMARTpool, against I!B"  (GeneBank 
no. NM_001005474, NM_031419) was purchased from Dharmacon (Lafayette, CO). 
Silencer Negative control #1 siRNA was purchased from Ambion (Austin, TX). HFF 
cells (3x105) (ATCC-CCL110) were washed and resuspended in 150 µl siRNA 
electroporation buffer (Ambion, Austin, TX). In a 1-mm gap cuvette, 150 µl of cells were 
mixed with 100 pmol siRNA and electroporated four times at 150V, 400 µs, 10 s between 
pulses. Subsequently, cells were placed at 37°C for 10 min and then transferred to 24-
well plates with 500 µl pre-warmed medium per well. After incubation at 37°C/5%CO2 
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for 72 hours, siRNA-treated cells were mocked infected or infected with B virus at m.o.i. 
10. Total RNA was at 1, 2, 3, 4, 5 and 6 h p.i. using TRI reagent (MRC Inc., Cincinnati, 
OH) according to the manufacturer's instructions. Real-time RT-PCR of specific NF-!B 
target genes (e.g. IL-6, IL-8, CXCL1, CXCL2, CXCL3, CCL2) was performed by using 
Prism 7900-HT sequence detection systems (Applied Biosystems, Foster City, CA). To 
determine I!B" gene knock down rate, relative changes in I!B" gene expression of 
siRNA-treated samples v.s. mocked infected cells were determined by using the relative 
standard curve method for quantification according to the manufacturer's instructions. To 
compare cytokine gene expression between B virus infected I!B" knockdown cells 
versus negative control siRNA-treated B virus infected cells, relative changes in gene 
expression were determined by using the relative standard curve method for 
quantification as well. 
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SECTION III. RESULTS 
 
Part 1. Development of a human cell culture model system to investigate the early 
host responses to B virus infection.  
 
B virus and HSV-1 growth kinetics in human foreskin fibroblasts. To simulate the 
initial encounter experienced by B virus at the onset of a zoonotic infection, human 
foreskin fibroblasts grown in culture were chosen as the in vitro cell culture model, 
because they are likely to be one type of target cells infected in vivo. They have been 
shown to be productively infected, and produce HSV-1 viral proteins in vitro (126). B 
virus and HSV-1 stock propagated from Vero cells, maintained between passages 130-
140, were titrated on both Vero and HFF cells to compare the plating efficiency on 
different cell lines. This was used to establish that the replication kinetics and virus 
replication were equivalent over the same time periods.  In essence, this technique was 
used as an outcome measurement that reflected the growth curve of these viruses in two 
different cell lines.  B virus has a ~4 fold reduction of plating efficiency on HFFs related 
to that on Vero, whereas the plating efficiency of HSV-1 on both Vero and HFFs has no 
significant difference.  The growth kinetics of B virus was slightly faster by 4-6 hours 
post infection than HSV-1 on HFFs, because the expression levels of immediate early (#) 
gene ICP0 and early ($) gene thymidine kinase (TK) in B virus infected cells at 3 h and 5 
h p.i. were higher than that observed in HSV-1 infected cells (Fig 1).  Molecular analysis  
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   a                                                                                                                                         
 
b 
 
Fig 1. Expression levels of ICP0 (a) and TK gene (b) from B virus and HSV-1 
infected HFFs.  Quantification of the PCR-amplified viral gene products was performed 
by densitometric analysis by using Kodak 1D Image analysis software. PCR band 
intensities were normalized to the band intensity of the control gene, $-actin.  
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of the kinetics of replication using measurement of #, $, and % classes of proteins that 
characterize alphaherpesviruses revealed the differences in replication kinetics.  
Collectively, these data provided a complete picture of the virus growth curves and 
formed the basis for subsequent infections to establish that identical virus loads were 
used in the comparisons of B virus and HSV-1 in HFF cells.  All HFF cells used in the 
subsequent experiments were derived from the same donor cells, which were expanded 
from the source cells provided by ATCC.  
 
Microarray experimental design. The early host cellular events induced by these two 
closely related simplexviruses, B virus and HSV-1, in a common cell type, human 
foreskin fibroblasts, were comparatively analyzed in microarray experiments using the 
Affymetrix human cDNA microarray U133 set to obtain a global snapshot of virus-
induced host cell gene activities at different time points post infection. Total cellular 
RNA isolated from duplicate infected samples at 1, 3 and 5 h p.i. was prepared for 
microarray analysis.  
To monitor microarray data quality, Affymetrix™ provides several controls to 
check variability associated with mRNA extraction and purification, cDNA synthesis, 
labeling and purification, and signal detection. These controls include B2 Oligo 
hybridization performance on the boundaries of each gene chip, the average background 
and noise values, Poly-A controls (B. subtilis genes dap, lys, phe, thr, and trp) to check 
the entire target labeling process, hybridization controls to evaluate sample hybridization 
efficiency (E. Coli genes BioB, bioC, bioD and P1 bacteriophage gene ‘cre’), the internal 
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control genes ($-actin and GAPDH) to assess RNA sample and assay quality, and the 
number of probe sets called “present” relative to the total number of probe sets on the 
array. All of chips used for these studies passed all control criteria a requisite before data 
were accepted for analyses. 
 
Although Affymetrix Data Mining Tool™ (DMT) can filter genes of interest 
based on the thresholds of certain quantitative and qualitative parameters, it is not a 
powerful tool in terms of data normalization and statistical analysis, both which were 
deemed to be important in this comparative analysis. Obvious differences in sensitivity 
and specificity have been substantiated among the different analysis methods. As a result, 
Robust Multichip Average™ (RMA) methods were implemented in the Bioconducting 
microarray analysis software to perform image-processing and data normalization, since 
RMA provides more accurate measurements of gene expression levels on gene chips (74) 
(1). These analyses were done in collaboration with Emory University’s microarray 
facility, BIMCORE.  The essential differences between RMA and the other methods are 
that RMA uses log-transformed perfect-matched probe signals on gene chips; it carries 
out a global background adjustment and across-array normalization using a formula that 
is based on a normal distribution; and it uses a linear model to estimate expression values 
on a log scale.  
 
 To identify a list of genes with statistically significant changes, stringent selection 
criteria were used by analysis of variance analysis (ANOVA, p-value) and false-
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discovery rate (FDR or q-value) analyzing these studies. Fold change is a popular method 
to evaluate if a gene is differentially expressed. The drawback is that it is considered to 
be an inadequate statistical test, because it does not offer variance and confidence of the 
analyzed data (104) (21), both important points essential to robust interpretation of the 
experiments presented in this dissertation. ANOVA is a simple and effective alternative 
method to fold-change method. It estimates the probability (p value) that a difference in 
expression could have been observed by chance. To establish p value thresholds better, 
the emerging consensus in the microarray data analysis field (1) suggests that FDR (10), 
which is the fraction of false positives within a list of genes exceeding a given statistical 
cutoff, is more practical for dealing with the testing of multiple hypotheses within a 
single study in the microarray experiments. These statistical methods allow operator 
control of errors in a carefully designed studies. 
 
Kinetic analysis of cellular gene expression after B virus and HSV-1 infection of 
HFF cells. To define early cellular signaling during B virus and HSV-1 infection in HFF 
cells, expression patterns of cellular genes during a 5 h period after virus inoculation 
were explored using human gene microarrays. Figure 2 provides an overview of the 
cellular gene expression patterns from B virus and HSV-1 during the first 5 hours of 
infection. In the first hour of incubation at 4°C, viruses were generally assumed to be 
only attached to cells, but had not penetrated into the cells (71) (95) because the growth 
properties of B virus resemble typical herpesvirus-characteristic replication (139) (67) 
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Fig 2: Hierarchical cluster analysis of DNA microarray data obtained from B virus and HSV-1 infected cells post 1 h, 3 
h, and 5 h infection in HG-U133 set chips. Each square in the heat map represents the average normalized expression level of 
a given gene per condition. Red represents increased expression and blue represents decreased expression compared to the 
mean of all normalized gene expression levels across all gene chips. Samples with similar gene expression profiles are 
clustered together. The color bar represents normalized expression scale.   
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(166). The gene expression patterns were not observed to change significantly in any 1 h 
p.i. samples with the exception of ne gene, IL-6ST (interleukin 6 signal transducer, 
gp130), which was induced by both B virus (2.0-fold) and HSV-1 (2.23-fold). Further 
correlation analysis by R-square test (data not shown) also supported that the host cell 
gene expression levels in each of the B virus, HSV-1, and mock-infected samples at 1 h 
p.i. correlated precisely. In part, this reflects the lack of metabolic activity due to the 4°C 
temperature, and this serves as the starting point from which all cells, infected and 
uninfected were released for subsequent measurements at 37°C in the subsequent 
experimental time points post infection. 
After incubation temperature was shifted to 37 °C for another 2 h (3 h p.i.) and 4 
h (5 h p.i.), host cell gene expression levels showed significant changes. More down-
regulated genes were observed than the numbers of up-regulated genes in each of virus 
infected cells. Interestingly, there were fewer genes that were up-regulated or down-
regulated in B virus infected samples than in HSV-1 infected samples at both 3 h and 5 h 
p.i.  
B virus-infected cells was found to have 16 up-regulated genes at 3 h p.i.,  while 
HSV-1 was found to have 136 up-regulated genes with at least 2-fold increase (Fig 3). 
Three genes were commonly up-regulated by both B virus and HSV-1 include Homo 
sapiens mRNA for Nef-attachable protein, nuclear factor of kappa light polypeptide gene  
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       Fig 3: Venn diagrams of differential and overlapping regulated host cell gene    
       numbers between B virus and HSV-1 infected samples at 1, 3, and 5 h p.i.
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enhancer in B-cells inhibitor zeta (NFKBIZ), and splicing factor proline/glutamine rich   
(SFPQ). In B virus infected cells, 178 genes were found to be down-regulated; whereas 
for HSV-1, 319 genes were down-regulated with 27 commonly regulated genes between 
B virus and HSV-1 groups. 
  
 At 5 h p.i., the number of down-regulated host genes was greater than the number 
of up-regulated cellular genes. Data sorted with at least 2-fold change revealed that there 
were 93 genes up-regulated and 1197 genes down-regulated in B virus infected cells; 
whereas there were 240 genes up-regulated and 2363 genes down-regulated in HSV-1 
infected cells. Between B virus and HSV-1 infected cells, there were 31 commonly up-
regulated genes and 742 commonly down-regulated genes. Among the 31 commonly up-
regulated genes, six genes were transcribed sequences with unknown functions, and the 
others included early growth response 1, cytoplasmic polyadenylation element binding 
protein 2, zinc finger SWIM domain containing 6, PRO1073 protein, Homo sapiens 
mRNA for Nef-attachable protein, UDP-glucose ceramide glucosyltransferase, Homo 
sapiens soggy-1 gene, SH3 domain and tetratricopeptide repeats 1, Down syndrome 
critical region gene, wingless-type MMTV integration site family member 1, POU 
domain, class 3 transcription factor 1, paired-like homeodomain transcription factor 3, 
transcription factor 8 (represses interleukin 2 expression), bridging integrator 3 and 
protease serine 22.  
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Biological functions of up-regulated genes in B virus and HSV-1 cells. Genes that 
were down-regulated were further sorted separately according to their q-values (q<0.002, 
and p-values (p<0.003). A total of 1000 genes with greatest fold-changes that passed q 
and p cut-off values from each time point were chosen for analysis of their biological 
functions.  Ingenuity™, pathway analysis software, was used for this purpose. In B virus 
infected cells, after 3 h p.i. (virus attachment at 4°C for 1 hour to preclude virus 
penetration, followed by 37°C incubation to allow penetration for 2 h), the top 1000 up-
regulated genes that mapped to the Ingenuity™ database can be classified into lipid 
metabolism, molecular transport, small molecule biochemistry, drug metabolism, gene 
expression, and other functions. HSV-1 induced a different set of genes relative to B 
virus gene expression, e.g., cancer genes, cell cycle, neurological disease, cellular 
growth, and proliferation functions, etc. To examine the significance of a given function 
of the virus induced genes at 3 h p.i., the five most significant functional groups induced 
by B virus were selected for comparison with HSV-1 and the results are shown in Fig 4a.  
At 5 h p.i. (virus attachment at 4°C for 1 h followed by 37°C incubation for 4 h), 
the majority of genes expressed was decreased in B virus and HSV-1 infected cells. 
Those genes that were found to have increased expression in B virus infected cells 
belonged to the functional group of cell-to-cell signaling and interaction, renal and 
urological system development, cellular development, nervous system development and 
function, and tissue morphology. HSV-1 induced genes can be classified into cell-to-cell 
signaling and interaction, cancer, cell death, neurological disease and cell cycle (Fig 4b). 
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          a 
 
 
 
 
 
 
 
 
           b 
 
 
 
 
 
 
 
 
 
Fig 4: Comparison of B virus (dark blue) and HSV-1 up-regulated genes functions 
(light blue with triangles) at 3 h (a) and 5 h (b) p.i. Functions are listed from most 
significant to least and the orange horizontal line denotes the cutoff for significance 
(equal to a threshold of 1:20, i.e. a 1 in 20 chance that the listed functions were associated 
with the genes from your dataset by random chance alone). 
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Biological functions of down-regulated genes in B virus and HSV-1 cells. The top 
1000 down-regulated genes with greater fold changes that passed q-values (q<0.002) and 
p-values (p<0.003) in B virus infected cells at 3 h p.i. were grouped into gene expression, 
cellular growth and proliferation, hematological system development and function, 
immune and lymphatic system development, and immune response. The down-regulated 
genes in HSV-1 infected cells at the same time point were involved in the embryonic 
development, tissue development, organismal development, auditory disease and cell 
morphology. The comparison of gene functions that were down-regulated between B 
virus and HSV-1 is shown in Fig 5a. 
The down-regulated genes in B virus infected cells at 5 h p.i. were related to the function 
of embryonic development, tissue development, cardiovascular system development and 
function, cellular growth and proliferation, and cellular assembly and organization, etc. In 
HSV-1 infected cells at 5 h p.i., the down-regulated genes’ functions were found in 
cancer, gastrointestinal disease, genetic disorder, cardiovascular disease and cell 
morphology (Fig 5b). 
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Fig 5: Comparison of B virus (dark blue) and HSV-1 down-regulated genes 
functions (light blue with triangles) at 3 h (a) and 5 h (b) p. i. Functions are listed 
from most significant to least and the orange horizontal line denotes the cutoff for 
significance (equal to a threshold of 1:20, i.e. a 1 in 20 chance that the listed functions 
were associated with the genes from your dataset by random chance alone). 
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Biological network affected by B virus and HSV-1 infection. To explore molecular 
relationships between the observed transcripts that had statistically significant changes 
(q<0.002, p<0.003), networks associated with biological functions were generated by 
Ingenuity™ pathway analysis tool, and the results are shown in Table 2 & 3. Five 
networks within up-regulated genes were found in HSV-1 at 3 h p.i., and these were 
involved in inflammatory disease, cell-to-cell signaling and interaction, hematological 
system development, cell death, gene expression, cancer, cell morphology, cellular 
movement, cellular development, cellular comprise, and dermatological diseases and 
conditions. Interestingly, the first network that has been observed in HSV-1-infected cells 
regulated many cytokines that were related to the NF-!B pathway. Similar functional 
networks were also found in B virus infected cells, but the expression levels of these up-
regulated genes that composed of this network were all less than a 2-fold change, except 
for NFKBIZ.  At 5 h p.i. analysis of B virus infected cells revealed three networks within 
the up-regulated genes and were found to be related to cellular growth and proliferation, 
cellular development, tissue development, cardiovascular disease, organismal injury and 
abnormalities, tissue morphology, and hematological system development and function. 
In HSV-1 infected cells, 5 major networks were found within the up-regulated genes, 
associated with cell-to cell signaling interaction, hematological system development and 
function, cellular movement, cellular growth and proliferation, gene expression, cell 
death, reproductive system disease, cellular development, cancer.  
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Table 2. Biological network affected by B virus and HSV-1 infection at 3 h p.i. Ingenuity Pathways Analysis computes a 
score for each network according to the fit of that network to the user-defined set of Focus Genes. The score indicates the 
likelihood of the Focus Genes in a network being found together due to random chance. A score of 2 indicates that there is a 1 
in 100 chance that the Focus Genes are together in a network due to random chance. Therefore, scores of 2 or higher have at 
least a 99% confidence of not being generated by random chance alone. 
 Net Genes Score Top Functions 
 1 AIF1, BCL3, CABP1, CCL24, CCRN4L, CP, CPB2, CYP2E1, DUSP5, F12, GAD1, 
GAD2, GAS6, HGFAC, IL1B, IL1RL1, ITGAX, LCN2, LYL1, MARCKSL1, MUC5AC, 
NFKB1, NFKB2, NFKBIA, NFKBIE, NFKBIL2, NFKBIZ, NRAP, PBEF1, PIM3, RELB, 
TNFAIP2, TNFAIP3, YY1, ZA20D2 
46 Gene Expression, 
Dermatological Disease and Conditions, 
Inflammatory Disease 
B 
virus 
3 h 
2 ADRB3, ARID3A, BTK, CD19, CHGA, CHKA, CSF3R, DNM2, EMR1, ERG, FCERG, 
GAS, GNA01, GRIN1, GRIN2A, GRIN2D, HNRPD, IRF8, JUND, KIAA1893, KLF16, 
NPFF, PCBP2, PDPK1, PRKCE, PTPN5, RCOR1, RUNX1, SAP30, SP3, SPI1, SPIB, SRC, 
SYNGAP1, TCF7L2 
46 Cellular Development, 
Immune and Lymphatic System Development and 
Function,  
Hematological System Development and Function 
 3 APOA1, APOE, ARID1A, ATF3, C1QL1, CETP, CHES1, CRSP7, DYRK1A, ESR1, FBP1, 
GADD45A, HNF4A, IL1RN, ING1, LBP, LIPA, MAPT, MARK4, NCOR1, NFATC3, 
PNRC1, POMC, PRLH, RANBP9, SFTPB, SFTPC, SLC19A1, SMARCA4, SMARCD1, 
STK11, TFAP2C, TITF1, WNT1, ZNF335 
46 Lipid Metabolism, 
Molecular Transport,  
Small Molecule Biochemistry 
     
 1 BCL3, BDKRB1, CCL2, CCL20, CCRN4L, CD83, CXCL2, CXCL3, CXCL6, DUSP5, 
ECGF1, ELF3, F3, G0S2, GCH1, GDF15, IER3, IL1B, IL6R, KLF10, MARCKSL1, MAZ, 
MT1E, NFKB1, NFKBIE, NFKBIZ, PBEF1, PHLDA1, PIM3, PLK3, PTGES, PTX3, REL, 
SPHK1, TNFAIP2 
46 Inflammatory Disease, 
Cell-To-Cell Signaling and Interaction, 
Hematological System Development and Function 
HSV 
3 h 
2 ACOX1, ALCAM, ARID4A, ATF3, BCL2L11, BTG2, C5orf13, DUSP7, EGR1, EGR4, 
EPAS1, ERN1, FOSL1, GADD45A, GADD45B, GAL, IL6, IL1RL1, ING1, JUNB, KLF5, 
LDLR, MCL1, NAB1, PDGFA, PPP1R15A, PRDM1, SIRT1, SOD2, STATIP1, STK11, 
TWIST1, WNT1, XBP1, ZFP36 
46 Cell Death, 
Death Expression,  
Cancer 
 3 ADM, BRD2, CALD1, CEBPD, CKS2, DLX2, DUSP6, EIF4A1, FTH1, GCN5L2, 
GTF2A2, ID2, KLF2, LIF, METAP2, MNT, MSX1, MSX2, MXD1, MYC, NGFB, NSEP1, 
p44S10, RELB, RPL10, RPL13, RPS6, RPS16, SP3, TAF4, TAF10, TNC, UBE2S, YAF2, 
YY1 
46 Gene Expression, 
Cancer, 
Cell Morphology 
 4 BDKRB2, COMP, CTSG, CYR61, DDX39, EDN1, ELL, EREG, FOS, FOSB, GAS5, 
GLCCI1, HBEGF, ICAM1, IL8, ITGB2, KLF6, MAP3K8, MAP3K14, NFATC1, NFKB2, 
NFKBIA, NR3C1, NTF3, PLAU, PLAUR, PPP2R2A, PTGS2, PVALB, SERPINB2, 
SERPINE2, TNFAIP8, TPM4, TSC22D3, VEGF 
46 Cell Death,  
Cellular Movement,  
Cell-To-Cell Signaling and Interaction 
 5 ABI1, ARHGEF2, BCL6, BCOR, BYSL, CCL7, CHKA, CXCL1, DUSP1, EGFR, EGR2, 
ETS2, GTPBP1, HOXA3, HOXA9, HOXC8, HOXD10, IER2, JUN, KRT18, MAFB, 
MAFF, MAFG, MAP2K3, MAP3K1, MAPK8IP3, MLL, PKNOX1, RBBP6, RPL4, SDC4, 
SNAI1, SOS2, TGIF, WSB1 
46 Cellular Development, 
Cellular Compromise, 
Dermatological Disease and Conditions 
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Table 3. Biological network affected by B virus and HSV-1 infection at 5 h p.i. Ingenuity Pathways Analysis computes a 
score for each network according to the fit of that network to the user-defined set of Focus Genes. The score indicates the 
likelihood of the Focus Genes in a network being found together due to random chance. A score of 2 indicates that there is a 1 
in 100 chance that the Focus Genes are together in a network due to random chance. Therefore, scores of 2 or higher have at 
least a 99% confidence of not being generated by random chance alone.  
 Net  Score Top Functions 
 1 ACVR1B, ASCL1, TOH1, BHLHB3, BMP7, CCL11, CCL14, EPAS1, GAD1, GAL3ST1, 
HAND1, HES1, HES5, IGSF1, INHA, KIAA1036, LYL1, MATK, MEF2C, MEF2D, 
NFATC3, NODAL, NRG1, PDGFB, PHKG1, POU3F1, SCGB1A1, SEMA3B, SFTPB, 
SMAD6, SNCG, STC1, TCF3, TITF1, VEGF 
45 Cellular Growth and Proliferation, 
Cellular Development,  
Tissue Development 
 
B 
virus 
5h 
2 APOA1, APO3, AVP, C1QL1, CAMKB, CCKBR, CETP, CHGA, CRLF2, DGKQ, DNM2, 
EVPL, GAS, GFAP, GNAO1, GRIN1, GRIN2A, GRIN2D, IVL, KIAA1893, LDLR, OPRL1, 
POMC, PRKCE, PRKCG, PTPN5, RELN, SLC19A1, SRC, SYNGAP1, TCF7L2, TFAP2A, 
TFAP2C, TNRC6A, WWOX 
45 Cardiovascular Disease, 
Organismal Injury and Abnormalities, 
Tissue Morphology 
 3 CD19, CD28, CD209, CSF2, CSF2RA, CSF3R, CUL3, EGR1, EGR4, FYB, HGF, GNRPC, 
IL1RL1, IL5RA, IRF8, IRS4, ITGAX, LCP2, MAFF, NFE2, SLC6A6, SOCS3, SPI1, TG, 
WT1, ZNF224 
45 Cellular Growth and Proliferation, 
Cellular Development, 
Hematological System Development and Function 
     
 1 AMPD3, CCL2, CCL7, CCRN4L, CD14, CEACAM1, CXCL2, CXCL3, CXCL6, DSCR1, 
DUSP5, FUT7, GCH1, GDF15, GUCA2A, ICAM1, IL8, IL1B, IL1F6, IL1RN, IL6R, ITGAM, 
KLF10, LCN2, MUC5AC, NFKB1, NFKBIZ, PIM3, PRTN3, SDFR1, SELPLG, SLFN5, 
THBD, TNFAIP2, UGCG 
45 Cell-To-Cell Signaling and Interaction, 
Hematological System Development and Function, 
Cellular Movement 
 2 ADRA1D, ARC, ATP8A2, BATF, BRD2, CCNT1, CEBPD, CYP17A1, CYP2E1, DUSP1, 
E2F2, EGR1, GADD45A, GADD45B, GADD45G, HLA-DQB1, HLA-DRA, IL6, IL19, 
IL1RL1, IRF1, JUNB, LIF, MHC2TA, NCOR2, NR1I2, NR4A1, OAS1, POMC, PPP1R15A, 
SOCS1, SOD2, SPEN, TFF2, XBP1 
45 Cellular Growth and Proliferation,  
Gene Expression, 
Cell Death 
HSV 
5h 
3 BCL2L11, CAPZB, CD19, CEBPE, CKS2, COX6A1, DPYSL5, DUSP4, DUSP6, EGR4, 
EIF4A1, EZH1, FOXO3A, HERC5, HUMMLC2B, ID1, IER3, KLF2, MATK, METAP2, 
MYC, MYCN, NGFB, NOL5A, NRG1, PHKG1, PTMA, RPL10, RPS12, SARDH, SGK, 
TNRC6A, UGT1A6, WT1, XIST 
45 Cell Death, 
Reproductive System Disease, 
Cellular Development 
 
 4 ATF3, BCL3, CAMK2A, CUL3, EDN1, EGFR, ELK4, ELL, EREG, FOS, FOSB, FOSL1, 
GAS5, HBEGF, HGF, IER2, IGHM, IGKC, IL11, IRX5, ITGB4, NTF3, PLAU, PLAUR, 
RPS6KA4, SLC19A1, SNX13, SYNGAP1, TACR1, TFAP2C, TLL2, TPSAB1, UBASH3A, 
VWF, WWOX 
45 Cellular Growth and Proliferation, 
Cellular Movement, 
Cell-To-Cell Signaling and Interaction 
 5 ATOH1, BMP7, CCL14, CDKN2A, CXCL1, CYR61, EVPL, F3, FOXA2, FOXC2, GTSE1, 
ID3, IVL, KIAA1036, LIPE, MAP3K8, NFKB2, NFKBIA, NR3C1, OPRL1, PDE8A, PNOC, 
PRKCE, TGS2, RELB, RPL10A, RUNX1, SEMA3B, SKP1A, SNCG, SNTB2, STC1, TBX3, 
TGIF, VEGF 
45 Cellular Movement,  
Cancer, 
Cellular Development 
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Confirmation of micrarray data by real-time RT-PCR. A total of 40 samples with 
duplicates spanning a wide range of expression levels across different time points in the 
microarray experiments were selected for validation by real-time RT-PCR of fold- 
changes between virus-infected cells and mock-infected cells. Results are shown in Table 
4. The genes with less than 2-fold relative gene expression change between virus- 
infected and mock-infected cells were all confirmed by real-time RT-PCR with the 
exception of IL1!, which was highly induced in HSV-1-infected cells at both 3 h and 5 h 
p.i. All genes with more than 2-fold change in microarray data were also confirmed to be 
up-regulated by real-time RT-PCR, but generally the extent of fold-change obtained from 
real-time RT-PCR data was significantly greater than data calculated from microarray 
hybridization signals.                                    
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Table 4. Validation of icroarray data with real-time RT-PCR. Data are represented as fold change (+/-SD) comparing virus 
infected samples to mock-infected samples. (-: Not changed or absent) 
 
 
Gene 
family and 
gene name 
GeneBank 
no. 
 Microarray 
fold change 
    Real-time PCR 
   fold change 
  
  BV3h BV5h HSV3h HSV5h  BV3h BV5h HSV3h HSV5h 
IRF-1 NM002198 
202531_at 
1.23 0.66 3.95 2.59  1.61 
+/-0.08 
0.82 
+/-0.07 
9.89 
+/-0.54 
4.14 
+/-0.22 
IL1! NM_000576 
205067_at 
1.26 1.18 1.91 1.79  0.44 
+/- 0.03 
0.22 
+/- 
0.01 
30.09 
+/-1.65 
17.84 
+/-0.63 
IL8 
(CXCL8) 
NM_000584 
211506_s_at 
-0.56 -1.11 31.46 6.90  0.94 
+/-0.05 
0.24 
+/-0.01 
30.59 
+/-1.78 
8.50 
+/-0.44 
(p105) 
(p50 
precursor) 
NM003998 
209239_at 
239876_at 
1.35 1.11 3.51 
 
1.53 
1.77  1.01 
+/-0.05 
0.44 
+/-0.04 
1.94 
+/-0.04 
1.86 
+/-0.17 
NFKBIZ NM_031419 
223218_s_at 
4.36 1.56 11.91 2.99  7.61 
+/-0.37 
3.05 
+/-0.14 
20.06 
+/-2.72 
13.50 
+/-0.87 
CXCL1 NM_001511 
204470_at 
-1.07 -1.32 20.82 8.30  0.77 
+/-0.03 
0.18 
+/-0.01 
25.67 
+/-1.17 
12.16 
+/-0.62 
CXCL2 M57731 
209774_x_at 
- 1.22 33.45 3.43  1.69 
+/-0.06 
0.69 
+/-0.03 
56.27 
+/-2.01 
10.89 
+/-0.56 
CXCL3 NM_002090 
207850_at 
1.08 1.06 23.50 6.93  1.31 
+/-0.05 
0.47 
+/-0.02 
46.65 
+/-2.13 
12.49 
+/-0.88 
CCL2 S69738 
216598_s_at 
- 1.09 5.30 6.73  0.57 
+/-0.02 
0.62 
+/-0.03 
5.83 
+/-0.21 
9.37 
+/-0.48 
IL6 NM_000600 
205207_at 
-1.64 -1.33 5.06 2.53  0.46 
+/-0.03 
1.19 
+/-0.05 
4.05 
+/-0.24 
9.25 
+/-0.50  
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Part 2. Identification of virus-mediated human host cell responses at early time 
points of infection that target immune cells. 
 
Host cell immune response genes regulated by B virus and HSV-1 at early times post 
infection.  To identify immune response genes regulated during the initial wave of virus 
infection, genes with expression changes if at least 2-fold were sorted, and the 
hierarchical cluster analysis results are shown in Fig 6. Most of these genes that were 
involved in either innate or adaptive immune responses were up-regulated at 3 h or 5 h 
post HSV-1 infection. Only a few genes were found to be up-regulated in a border range 
of 2-fold change post B virus infection, i.e., EGR3 and NFKBIA gene. Furthermore, 
some immune responsive genes were found to be down-regulated in B virus infected 
cells, e.g., GADD45B, F3, IER3, SMAD7, IER3, SMAD7, FOS, HOXA9 and CDKN1B. 
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 208937_s_at (ID1) 
                                                                                                                                              
                                                                                                                                               208937_s_at (ID1)    
 
 
 
 
 
 
 
 
 
 
 
                           HSV1h       BV1h       HSV3h     HSV5h       BV3h        BV5h 
Fig 6. Hierarchical cluster analysis of immune responsive genes with at least 2-fold 
change genes. Each square in the heat map represents the average normalized expression 
level of a given gene per condition. Red represents increased expression and blue 
represents decreased expression compared to the mean of all normalized gene expression 
levels across all gene chips. Samples with similar gene expression profiles are clustered 
together. The color bar represents normalized expression scale. 
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IFN signaling pathway. IFNs are cytokines with antiviral and immunomodulatory 
functions. So far more than 300 genes have been identified as IFN-stimulated genes (41) 
(39) and provide part of the innate immune response. Each host cell gene that was 
involved in IFN signaling pathway and had significant changes in any of virus infected 
samples were therefore sorted and compared, the results of which are shown in Fig 7.  
Only less than 1% of IFN-related genes were found to have significant changes in HSV-1 
infected cells and none of these genes were up-regulated in B virus infected cell. IRF-1 
was initially described as a positive transcription factor for the regulation of type I IFNs 
(IFN-!/") and IFN-inducible genes (105) (35). In our microarray data, IRF-1 was up-
regulated by HSV-1, but not by B virus. Quantitative RT-PCR confirmed that IRF-1 had 
a 9.89-fold increase at 3 h post HSV-1 infection and had a 4.14-fold increase at 5 h p.i. 
relative to B virus (Table 4), each value greater than those observed in B virus infected 
HFF cells (1.61-fold at 3 h p.i. and 0.82-fold at 5 h p.i.). The IFNAR2 the gene encoding 
the type I IFN receptor, showed a 2.7-fold increase at 3 h post HSV-1 infection, but not in 
B virus infected cells. Interestingly, an IFN-signaling inhibitor called suppressor of 
cytokine signaling-3 (SOCS3) was also observed to have about 3-fold induction during 
the first 5 hours of HSV-1 infection period, but not in B virus infected cells. 
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                HSV1h       BV1h        BV5h       HSV3h      HSV5h      BV3h 
 
 
 
 
 
Fig 7. Hierarchical cluster analysis of IFN-related genes from microarray data in B 
virus and HSV-1 infected samples at 1, 3, and 5 h p.i. Each square represents the 
average normalized expression level of a given gene per condition. Red represents 
increased expression and blue represents decreased expression. Samples with similar 
gene expression profiles are clustered together. The color bar represents normalized 
expression scale. 
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Cytokines and chemokines. To identify which cytokines and/or chemokines were 
induced after infection with B virus or HSV-1, we initially measured expression of IL-6, 
IL-11, LIF, and chemokine genes CXCL1, CXCL2, CXCL3, CXCL6, CXCL8 (IL-8), 
CCL2, which were found to be up-regulated in HSV-1-infected cells compared to mock-
infected cells, but not in B virus-infected cells (Fig 8). Chemokine genes, e.g., CXCL1, 
CXCL2, CXCL3 and CXCL8 (IL-8), were expressed, with ~20- to 33-fold change in 
HSV-1-infected samples at 3 h p.i., although the expression levels declined to ~ 3- to 8-
fold at 5 h p.i. Strikingly, there were no cytokine or chemokine genes induced in B virus 
infected cells. Real time RT-PCR validated that HSV-1 not only induced CXCL1, 
CXCL2, CXCL3, CXCL8 (IL-8) and IL-6, but also increased the expression level of IL-
1". However, no cytokine or chemokine genes in B virus-infected samples showed 
significant differences, with less than 2-fold changes in expression levels compared to 
mock-infected samples (Table 4).  
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                      HSV1h       BV1h      HSV3h     HSV5h      BV3h       BV5h 
 
 
Fig 8: Hierarchical cluster analysis of cytokine genes from microarray data in B 
virus and HSV-1 infected samples at 1, 3, and 5 h p.i. Each square represents the 
average normalized expression level of a given gene per condition. Red represents 
increased expression and blue represents decreased expression. Samples with similar 
gene expression profiles are clustered together. The color bar represents normalized 
expression scale. 
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HSV-1 infected cell supernatants had greater neutrophil chemoattractant activity 
than B virus infected cell supernatants. To determine whether functional differences 
existed between virus-mediated cytokine or chemokine responses to target immune cells, 
neutrophil chemotaxis assays were used. In prior microarray datasets, a set of cytokines 
and chemokines genes, e.g. IL-1", IL-6, IL-11 CXCL1, CXCL2, CXCL3, CXCL6, 
CXCL8 (IL-8), and CCL-2, were noted to have been induced in HSV-1-infected cells, but 
not in B virus-infected cells. Because most of these cytokines and chemokines produced 
from HSV-1-infected HFF cells had the ability to induce neutrophil chemotaxis activities, 
a neutrophil (PMN) transmigration assay was performed to assess the ability of cytokines 
and chemokines secreted from HSV-1-infected cells to facilitate neutrophil movement. In 
contrast, B virus-infected cells were not expected to have detectable neutrophil 
chemotaxis activites. To our surprise, B virus infection was associated with less 
neutrophil chemoattractant activity compared to mocked-infected cell supernatants (Fig 
9), suggesting that B virus inhibited neutrophil transmigration. Comparing neutrophil 
chemoattractant activity between B virus and HSV-1 infected cell supernatants, however, 
revealed that HSV-1 induced signigicantly greater chemoattractant activity, as predicted 
by the microarry data neutrophil transmigration rate was further quantified by measuring 
the activity of myeloperoxidase (MPO), a unique enzyme present in neutrophils (Fig 10). 
Although we observed less neutrophils transmigration in B virus-infected cell 
supernatants compared to mocked-infected cell supernatants (Fig 9), there was no 
significant difference in neutrophil transmigration rate between B virus- and mock-
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                               1h sup.                2h sup.                   3h sup.                 4h sup.                 5h sup.                 6h sup.                      
 
          mock 
 
 
         B virus 
 
 
           HSV 
 
 
                                                    Positive control                                                                Negative control 
                                                    (10-7M fMLP)                                                                        (EMEM) 
Fig 9. Neutrophil transmigration towards supernatants from B virus, HSV-1 and mock infected HFFs. Supernatants 
were harvested from cultures of infected or uninfected HFFs hourly. In the transwell setups, freshly prepared human 
neutrophils were added to 5 µm pore size filters and virus infected cell supernatants were added in the bottom wells. The 
migration of neutrophils across the transwells was photographed from the receiver wells. All supernatants samples were tested 
in duplicate wells. (EMEM: Eagles minimum essential medium; Sup.: supernatant) 
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Fig 10. Quantification of transmigrated neutrophil numbers in B virus, HSV-1 and 
mock infected cell supernatants. Supernatants were harvested from cultures of infected 
or uninfected HFFs hourly and tested in a transmigration assay. The % of neutrophils 
transmigrating across the transwells was quantified by measuring MPO activity. All 
supernatant samples were tested in duplicate wells. 
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infected cell supernatants according to unpaired student t-test statistical analysis 
(P>0.05).  
 
HSV-1, but not B virus induced IL-8 production. To further identify what caused virus 
infected cell supernatants to have neutrophil chemoattractant activity, we measured IL-8 
by ELISA because this chemokine was one of the major mediators of the inflammatory 
response and functions as a chemoattractant. According to our previous microarray data, 
elevated IL-8 gene expression levels had been found in HSV-1-infected HFF cells (31-
fold increased at 3 h p.i. and 7-fold increased at 5 h p.i.), but not in B virus-infected HFFs 
(0.6-fold decreased at 3 h p.i. and 1.1-fold decrease at 5 h p.i.). The IL-8 ELISA results 
(Fig 11) showed that B virus- and mock-infected cells produced similar IL-8 amount 
during the first 6 hour infection period. However, HSV-1 induced higher IL-8 than mock- 
and B virus-infected cells during all 6 hours post infection. This data supported our 
microarray data and may explain why more chemoattractant activity was found in HSV-1 
infected cell supernatants than B virus infected cell supernatants in the above neutrophil 
transmigration experiment. 
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!
Fig 11. Comparison of IL-8 productions in B virus, HSV-1 and mock-infected cell 
supernatants. Supernatants were harvested from cultures of infected or uninfected HFFs 
hourly. IL-8 concentrations were measured by ELISA. (n=3). Values are the means ± 
standard deviations. 
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The inhibitory effects of virus infected cell supernatants to neutrophil 
transmigration. Since there was no neutrophil transmigration activities observed in B 
virus-infected cell supernatants except in 1 h p.i. cell supernatants, we were interested to 
know if it could be due to the presence of any inhibitor besides the fact that no 
chemoattractants were found in B virus-infected cell supernatants (Fig 9 & Fig 10). 
Neutrophil transmigration inducers IL-8 and fMLP were therefore mixed with virus 
infected cell supernatants (n=4) and the neutrophil transmigration rates toward IL-8 or 
fMLP treated samples were compared to the controls that only had IL-8 or fMLP, but no 
virus infected cell supernatants (Fig 12, 13 and 14). The result showed that B virus- 
infected cell supernatants caused both IL-8 and fMLP-mediated neutrophil transmigration 
rate to be reduced, and this inhibitory effect was greater at later time points (Fig 15 & 
16). HSV-1-infected cell supernatants showed the same trend as B virus in inhibiting IL-
8-mediated neutrophil transmigration (Fig 15), but HSV-1 had a greater inhibitory effect 
in fMLP-mediated neutrophil transmigration at the earliest time point (1 h p.i.) and less 
inhibitory effect at a later time point (5 h p.i.) (Fig 16). Mock-infected cell supernatants 
also showed reduced IL-8 and fMLP-mediated neutrophil transmigration rates, which 
suggested that there was a host cell-derived inhibitor present in the cell culture 
supernatants. 
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Fig 12. B virus infected cell supernatants-mediated inhibition to IL-8- and fMLP-induced neutrophil transmigration. 
The neutrophil transmigration inducers, 0.2 µM f-MLP or 200 ng/ml IL-8, were added into the lower chamber of the transwells 
setups, in addition to the presence of tested B virus-infected cell supernatants. Supernatants were harvested from cultures of B 
virus infected HFFs at 1 h, 3 h and 5 h p.i. The migration of neutrophils across the transwells was photographed from the 
receiver wells. All supernatant samples were tested in duplicate wells.  
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Fig 13. HSV-1 infected cell supernatants-mediated inhibition to IL-8- and fMLP-induced neutrophil transmigration. 
The neutrophil transmigration inducers, 0.2 µM f-MLP or 200 ng/ml IL-8, were added into the lower chamber of the transwells 
setups, in addition to the presence of tested HSV-1-infected cell supernatants. Supernatants were harvested from cultures of 
HSV-1 infected HFFs at 1 h, 3 h and 5 h p.i. The migration of neutrophils across the transwells was photographed from the 
receiver wells. All supernatant samples were tested in duplicate wells. 
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Fig 14. Mock infected cell supernatants-mediated inhibition to IL-8- and fMLP-induced neutrophil transmigration. The 
neutrophil transmigration inducers, 0.2 µM f-MLP or 200 ng/ml IL-8, were added into the lower chamber of the transwells 
setups, in addition to the presence of tested mock-infected cell supernatants. Supernatants were harvested from cultures of 
uninfected HFFs at 1 h, 3 h and 5 h p.i. The migration of neutrophils across the transwells was photographed from the receiver 
wells. All supernatant samples were tested in duplicate wells. 
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Fig 15. Quantitiation of virus infected cell supernatants mediated inhibition to IL-8-
induced neutrophil transmigration. The neutrophil transmigration inducers, 200 ng/ml 
IL-8, were added into the lower chamber of the transwells setups contaning mock-, or B 
virus- or HSV-1-infected cell supernatants. Supernatants were harvested from cultures of 
B virus, HSV-1 infected or mock-infected HFFs at 1 h, 3 h and 5 h p.i. The numbers of 
migrated neutrophils across the transwells were quantified by measuring MPO activity 
(n=4). 
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Fig 16. Quantitation of virus infected cell supernatants mediated inhibition to 
fMLP-induced neutrophil transmigration. The neutrophil transmigration inducers, 0.2 
µM f-MLP, were added into the lower chamber of the transwells setups containing  
mock-, or B virus- or HSV-1-infected cell supernatants. Supernatants were harvested 
from cultures of B virus, HSV-1 infected or uninfected HFFs at 1 h, 3 h and 5 h p.i. The 
numbers of migrated neutrophils across the transwells was quantified by measuring MPO 
activity (n=4). 
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Cytokine gene expression in infected human cells was involved in NF-!B pathway.  
The clear differences in the gene regulation responses of HFF cells to infection with 
HSV-1 or B virus suggested that virus infection had resulted in virus type-specific host 
cell interactions (Fig 6 & 8). Ingenuity™ pathway analysis tool was used to construct a 
biological network in order to connect the molecular relationships among transcripts 
involved in innate immunity to reveal disparate outcomes of each virus infection. Figure 
17 illustrates the interconnectedness of HSV-1 up-regulated host genes at 3 h p.i.; 
induction of NF-!B transactivated cytokines is apparent. A similar, but functionally 
different network, was also found in B virus-infected cells, the expression levels of these 
genes which composed this network showed less than a 2-fold change, except for 
NFKBIZ. 
 
 
Nuclear translocation of NF-!B p50. To test the hypothesis that the failure of cytokine 
gene induction in B virus-infected cells was due to the inhibition of NF-!B activation, the 
nuclear translocation of NF-!B p50 was quantified to measure the activation status in the 
nucleus after B virus and HSV-1 infection. The activation of NF-!B p50 was analyzed by 
Cellomics ArrayScan cytometer, which measured levels of NF-!B p50 translocation from 
the cytoplasm to nucleus, and represented these measurements as the difference in 
average fluorescent staining intensity between the nucleus and cytoplasm. 
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Fig 17. Biological network for NF-!B regulated immune responsive genes generated from HSV-1 3 h p.i. samples. The 
number next to each gene represent the fold change ratio comparing virus infected to mock-infected samples.  
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NF-!B can be activated by TNF-" phosphorylation dependent-ubiquitination and 
degradation of inhibitor of I!B proteins. Therefore, TNF-"-treated HFFs were used as a 
positive control for NF-!B p50 nuclear translocation, and the results are shown in Figure 
18. NF-!B p50 was also activated by both B virus and HSV-1 (Fig 19). The amount of 
NF-!B p50 translocation from cytoplasm to the nucleus in B virus and HSV-1 infected 
cells was similar at 1 h, 2 h, 5 h and 6 h p.i. However, HSV-1 induced more NF-!B p50 
nuclear translocation than B virus at 3 h and 4 h p.i. 
 
DNA binding activity of NF-!B p50. To examine if the DNA binding activity of NF-!B 
p50 was inhibited and therefore caused cytokine gene expression blocked in B virus 
infected cells, nuclear extracts prepared from B virus, HSV-1 and mock-infected cells 
were incubated with a probe containing an NF-!B p50 consensus binding site bound to 
ELISA plates. To rule out possible cross-contamination of nuclear extracts by 
cytoplasmic contents, cytoplasmic extracts from infected cells were also tested for NF-!B 
p50 DNA binding activity, and no NF-!B p50 DNA binding activity was observed (data 
not shown). According to current understanding, NF-!B p50 present in the cytoplasmic 
fraction is bound by its inhibitor protein I!B, and will not be available to bind DNA too.  
 
 
  
81 
 
 
 
Fig 18. Nuclear translocation NF-!B p50 in TNF-"-treated HFFs. HFFs cells were 
treated with TNF-" (0.1µg/ml) for 1 h and the amounts of NF-!B p50 translocation from 
the cytoplasm to nucleus is measured by Cellomics ArrayScan cytometer and represented 
as the difference in average fluorescent staining intensity between the nucleus and 
cytoplasm. Data are the means ± standard deviations (n = 500). 
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Fig 19. Nuclear translocation NF-!B p50 in B virus and HSV-1 infected HFFs. HFFs 
were B virus- or HSV-1- or mocked-infected at m.o.i. of 10 and the amounts of NF-!B 
p50 translocation from the cytoplasm to nucleus is measured by Cellomics ArrayScan 
cytometer and represented as the difference in average fluorescent staining intensity 
between the nucleus and cytoplasm. The ratio of nuclear to cytoplasmic fluorescence 
compared to that of mock-infected cells is calculated and the data are the means ± 
standard deviations (n = 500). 
  
  
83 
HSV-1 infection induced high levels of NF-!B p50 DNA binding activity, 
approaching the levels generated with the TNF" control (Fig 20). In B virus-infected 
cells, however, levels of NF-!B promoter binding activity mostly remained at mock 
levels. This suggests that one possible mechanism of the cytokine gene blockage in B 
virus-infected cells is due to the inhibition of NF-!B p50 DNA binding activity. These 
data collectively support the hypothesis under investigation based on the differences 
between HFF cells infected with B virus and the closely related family member HSV-1 
with regard to regulation of NF-!B dependent innate responsive genes expression.  
 
Tanscription factor genes. All of the transcription factors other than those in the NF-!B 
pathway and IFN signaling pathway regulated by B virus and HSV-1 are shown in Figure 
21. HFF cells infected with B virus were observed to show no induction of any 
transcription factors within the first 5 hours; however, HSV-1 was observed to up-
regulate 45 transcription factors with at least 2-fold change during the first five hours p.i. 
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Fig 20. NF-!B p50 DNA binding activity in B virus and HSV-1 infected HFF cell 
nuclear preparations. NF-!B p50 DNA binding activity was measured by ELISA. Data 
are the means ± standard deviations (n = 3). 
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Fig 21: Hierarchical cluster analysis of transcription factor genes from microarray 
data in B virus and HSV-1 infected samples at 1, 3, and 5 h p.i. Each square 
represents the average normalized expression level of a given gene per condition. Red 
represents increased expression and blue represents decreased expression. Samples with 
similar gene expression profiles are clustered together. The color bar represents 
normalized expression scale. 
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Part 3. Design of blocking strategies to circumvent early events in the infected cell to 
modulate immune responses. 
 
B virus inhibits NF-!B pathway by inducing a nuclear protein IkB# . To identify if 
there was any gene specifically induced in B virus infected cells that might cause the 
inhibition of NF-!B p50 DNA binding activity, hierarchical cluster analysis was used 
subsequently to sort all transcripts found to have significant changes related to the NF-!B 
pathway (Fig 22). Examination of NF-!B gene p100 (p52 precursor), p105 (p50 
precursor), REL (c-REL) and RelB revealed fold-increases of 2.21, 3.51, 3.61, 2.39, 
respectively, in HSV-1-infected HFF at 3 h p.i. None of these NF-!B genes was induced 
by B virus infection at 1, 3 or 5 h p.i. While the NF-!B negative regulators, viz., I!B# 
(NFKBIZ), IkB$ (NFKBIE), I!B" (NFKBIA), and BCL-3 were induced in HSV-1-
infected cells, I!B# (NFKBIZ) was found as the only NF-!B negative regulator that was 
highly induced in B virus- infected cells. Real-time PCR confirmed that B virus inducible 
I!B# (NFKBIZ) had a 7.61-fold increase at 3 h p.i., and 3.05-fold increase at 5 h p.i. 
(Table 4). Comparatively, HSV-1 inducible I!B#  (NFKBIZ) had a 20.26-fold increase at 
3 h p.i., and 13.50-fold increase at 5 h p.i.  
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Fig 22: Hierarchical cluster analysis of NF-!B pathway related genes from 
microarray data in B virus and HSV-1 infected samples at 1, 3, and 5 h p.i. Each 
square represents the average normalized expression level of a given gene per condition. 
Red represents increased expression and blue represents decreased expression. Samples 
with similar gene expression profiles are clustered together. The color bar represents 
normalized expression scale. (MAIL gene = NFKBIZ gene)  
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B virus and HSV-1 induce I!B#  mRNA in infected HFF cells. To monitor the I!B# 
mRNA expression levels in B virus infected cells during the first six hours of infection, 
relative changes of I!B# mRNA levels between virus- and mock-infected human foreskin 
fibroblast (HFF) cells were quantified using real-time PCR (Fig 23). I!B# mRNA 
expression levels in HSV-1 infected cells were also measured as a control. In B virus 
infected cells, I!B# mRNA expression level increased by 3 h p.i. peaking at 4 h p.i., after  
which expression levels declined. Similar expression profiles were observed in HSV-1 
infected cells, but the induction kinetics of the HSV-1 I!B# mRNA was ~ 1 h faster than 
that observed in B virus infected cells. The I!B# mRNA level in HSV-1-infected cells 
began to increase at 2 h p.i., reaching maximal levels by 3 h p.i., and then declined 
shortly thereafter.  Both viruses induced increases in expression levels of I!B#, albeit at 
different time points following infection. 
 
B virus and HSV-1 induce I!B#  protein accumulation in the nuclei. Since mRNA 
expression is not always translated into protein, I!B# protein translation was investigated 
by immunofluorescent staining, and images were acquired by confocal microscopy (Fig 
24 & 25). In both B virus and HSV-1-infected HFF cells, I!B# could be observed to be 
localized inside the nucleus within 2-6 hours following infection. Interestingly, I!B# was 
not evenly distributed in the nucleus.  It aggregated in distinct punctate-like structures 
and tended to be observed at the nuclear border. This result was similar to published 
description (155) of the subcelluar localization of I!B# and reports that I!B# co-localized 
with the nuclear corepressor SMRT (silencing mediator of retinoid and thyroid hormone  
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Fig 23. Kinetics of IkB#  mRNA level corresponding to B virus and HSV-1 infection. 
Total RNA extracted from B virurs-, HSV-1- and mocked infected cells at 1, 2, 3, 4, 5 ,6 
h p.i. was used as a templte to generate cDNA. Levels of IkB# mRNA were quantfied by 
real-time PCR and relative changes in gene expression were determined by using the 
relative standard curve method. 
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Fig 24.  Immunofluorescent staining of IkB!  in B virus-infected cell nuclei. HFFs were infected with B virus at m.o.i. of 
10 for 1, 2, 3, 4, 5 and 6 h. Cells were stained with anti-I"B! antibody (green) and nuclei were stained with Hoechst 33342 
(red). 
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Fig 25.  Immunofluorescent staining of IkB!  in HSV-1 infected cell nuclei. HFFs were infected with HSV-1 at m.o.i. of 
10 for 1, 2, 3, 4, 5 and 6 h. Cells were stained with anti-I"B! antibody (green) and nuclei were stained with Hoechst 33342 
(red).
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receptors) and HDAC5 (histone deacetylase 5) in the nucleus. Because not every cell was 
observed to be I!B" positive, cells were probably not evenly infected, or I!B" protein 
levels were too low to be detected in some cells. 
 
Expression of NF-!B target genes in B virus infected I!B"  knockdown cells. I!B" 
had been identified as a NF-!B inhibitor and is bound preferentially to NF-!B p50 (155) 
(169) (171). In vitro experiments indicated that the I!B" carboxyl-terminal domain with 
the ankyrin-repeats inhibits the DNA binding of the p65·p50 heterodimer as well as the 
p50 homodimer (171). To investigate whether one role of I!B" in B virus infected cells is 
to negatively regulate NF-!B activity in the nucleus, experiments were designed to 
measure NF-!B DNA binding activity under conditions of knockdown and restoration of 
I!B" during virus infection. RNA interference was used to knockdown the I!B" gene. 
The knockdown rates of I!B" gene for samples collected from each time point were 
shown in Table 5, and the average knockdown rate was 71.7%. The NF-!B transactivated 
target gene CCL2 had mRNA levels elevated at 4 h and 5 h post B virus infection, 
whereas CXCL1 and CXCL3 mRNA levels were elevated at both 4 h and 6 h in I!B" 
knockdown cells (Fig 26). These data suggest that B virus inducible I!B" correlated with 
inhibition of expression of the NF-!B regulated cytokine/chemokine gene CCL2, 
CXCL1, and CXCL3, and may be causally related. Other NF-!B transactivated target 
genes, IL-6, CXCL2, and IL-8, however, showed repressed mRNA levels post B virus 
infection in I!B" knockdown HFF cells, which suggested that I!B"-NF-!B complex is 
not the only factor regulating these cytokine genes in B virus infected cells. 
  
93 
 
 
 
 
 
Table 5. The average I!B"  knockdown rate of samples collected from each time 
point. (n=4). The expression level of I!B" were quantified by real-time RT-PCR and the 
percent of I!B" knockdown rate was determined by comparing the I!B" expression level 
between B virus infected I!B" siRNA-treated cells and B virus infected negative siRNA-
treated cells.  
 
Hour post infection 1 h 2 h 3 h 4 h 5 h 6 h 
I!B" knockdown rate 80% 74% 56% 61% 71% 88% 
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Fig 26. Cytokine gene expressions in B virus infected I!B"  gene knockdown HFF cells. Gene expression levels in B virus 
infected I!B" gene knockdown cells were quantified by real-time RT-PCR and compared to B virus infected negative control 
siRNA-treated cells. (A) I!B" knockdown enhances some cytokine genes. (B) Cytokine genes that are not enhance by I!B". 
Data are the means ± standard deviations (n = 4).      
(A)                        CCL2                                              CXCL1                                            CXCL3   
(B)                         IL-6                                               CXCL2                                             IL-8 
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SECTION IV. DISCUSSION 
 
Human cell culture model system of B virus infection 
B virus infection frequently results in deadly outcomes in foreign host systems.  
The reasons underlying the severe morbidity and mortality are poorly understood. B virus 
has co-evolved and adapted to have a productive relationship with macaque hosts, but 
encountering human hosts far less frequently has left both without a strategy for peaceful 
co-existence. As a result, human hosts suffer severe morbidity and frequent mortality as a 
result of B virus zoonotic infection. Primary human foreskin fibroblasts, one type of  
target cell and representative of those infected in vivo, were selected for these studies. 
Additionally, primary HFF cells in culture have regulated cell cycle machinery and 
become contact-inhibited when grown to confluence, mimicking the quiescent state of the 
dermis. As such, cultures of HFF cells infected with B virus were used as a model of 
foreign host cells to study the molecular events at early time points after B virus 
infection. To design a natural host infection model, the same cell type, HFF, was infected 
with HSV-1, because human cells are also the natural hosts to HSV-1 infection. 
 
Comparative analysis of virus-induced, global cellular transcriptional remodeling 
provided opportunities to examine previously published data on host gene expression in 
different cell types induced by different strains of HSV-1, as well as, for the first time, 
examine the events resulting from B virus infection (151) (111) (79) (129). Using 
growth-arrested cells for analysis of virus-induced host cell expression remodeling 
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generally reduces the variability of transcriptional activity, because cells are spread 
across the cell cycle and therefore represent the broadest spectrum of metabolic activities. 
The cell line used in these studies was asynchronous prior to virus inoculation. By using 
high m.o.i. (i.e. 10) to cause near simultaneous infection of all cells at the initial round of 
viral addition, the average behavior of all infected cells was measured. The replication 
kinetics of B virus proved faster, although not significantly faster, than that of HSV-1 
replication in HFFs (Fig 1). 
 
Using HFF cell cultures to serve as a model in which the events of host cell 
responses are mapped provides identification of potential targets for blocking or 
modulating pathogenesis to ultimately reduce morbidity, the establishment of latency, or 
virus reactivation. The field of virus-host interactions has progressed greatly in recent 
years, particularly with the help of more user-friendly bioinformatics tools as rich mines 
of data are gathered. Data obtained from cell lines, integrated with data from animal 
model studies, will ultimately lead to further understanding of B virus infection outcome 
in non-adapted foreign host cells. 
 
 
Adapted cell model system of B virus infection: macaque cells in culture 
B virus is indigenous in macaque monkeys, and disease in natural hosts, 
macaques, is often mild or inapparent. Are there differences in early innate host 
responses when B virus infects macaques vs. humans?  From the results of B virus 
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infection in human foreskin fibroblast cells, defective induction of innate immune 
response genes was observed, suggesting that B virus is not able to induce innate immune 
responses in human cells. Needless to say there are many limitations inherent in a cell 
culture model system when the ultimate goal is to understand B virus infection in 
humans, however, the virus dynamics within human cells in cultures provides a 
mechanism to examine molecular events of infection in a controlled microenvironment.  
Parallel to this B virus-infected human cell culture model, future studies with a B virus-
infected monkey cell culture model will provide a mechanism by which comparative 
analysis of the early cellular responses in cells from the natural host versus the foreign 
host can be performed. Preliminary microarray data from B virus-infected monkey cells 
(MK-2, rhesus monkey kidney cell) showed that immune response genes, including IFN-
!4, IFN-!5, IL-6 (IFN-"2), IRF1, IL-16, IL24, CD24, PLUNC, TNSF9, TRAF3IP2, 
MAP3K, ATF3, JUB, NR4A2, SCAP1, FGFR1 etc., were induced post 1 hour B virus 
infection at 37°C. Studies on the activation status of STAT-1 phosphorylation, which 
plays a role to regulate IRF-1 in IFN pathway, also demonstrated that B virus triggers 
IFN responses in the natural host cells, MK-2. The impact of these observations must be 
elucidated with future studies, but these preliminary results in vitro using macaque cells 
in culture a model system to study host responses to B virus infection. Currently, the data 
presented in this dissertation, however, strongly support that B virus infection in macaque 
cells result in induction of comparable cytokine responses to those seen in human cells 
infected with HSV-1. B virus in foreign host cells, however, results in no cytokine 
responses, suggesting that B virus effectively blocks the foreign host cytokine responses.  
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The implication is that the adaptation of macaques to B virus infection is similar to the 
adaptation of humans to HSV-1. The absence of these adaptive responses correlates with 
the absence of a neutrophil-based inflammatory response. Whether these observations 
correlate with the dramatic morbidity and mortality of B virus in foreign hosts requires 
many more studies, but forms the foundation for interesting speculation and the 
examination of a number of hypotheses.   
 
 
Microarray tools: snapshots in time of virus: host cell interactions 
DNA microarray technology is a powerful tool to study the simultaneous 
transcriptional expression of thousands of genes. The gene chips (human genome U133 
set, Affymetrix) that were used for these studies contained 45,000 probe sets representing 
more than 39,000 transcripts derived from ~33,000 well-documented human genes. 
Nevertheless, processing and mining the large amount of data generated by this high 
throughput technology are challenging, underscoring the need for statistical analysis and 
biological interpretation algorithms to determine what constitutes statistically significant, 
virus-specific host expression remodeling snapshots at time points following virus 
infection. 
 
In the microarray experimental design, an important issue is to determine how 
many replicates are optimal for statistical analysis. Power analyses often indicate that 
larger sample sizes increase sensitivity and specificity. Small samples sizes (two 
independent replicates) per condition (time and virus) in the experimental design of these 
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investigations coupled with efforts to maintain low FDR q value and ANOVA p value 
can result in low power to detect differential expression. These microarray data, however 
were used to gather the overall gene expression profile and to provide a snapshot of 
which genes were activated in the early stages of B virus infection in human cells in 
culture. Compensation to balance the low power problem was accomplished by obtaining 
an extensive list of genes with the lowest 1000 p- and q-value to be sorted for 
differentially expressed genes. Since microarrays were considered as semiquantitative 
assays, any gene expression levels of interest were more precisely analyzed using real-
time RT-PCR. 
 
In microarray experiments, another inherent problem is that the expression levels 
of non-coding genes, such as microRNAs (miRNAs) and siRNAs, were not detectable on 
gene chips.  In these experiments, although it was not clear whether there are any miRNA 
or siRNA sequences in B virus genome, at least one miRNA out of the predicted 13 
miRNA precursors were identified, while in HSV-1 genomes there have been 24 miRNA 
candidates (32) that may play important roles in redirecting viral defense functions of 
host cells (84). The discoveries of miRNAs encoded by other herpesvirus family, such as 
Epstein-Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus, mouse 
gammaherpesvirus 68, and human cytomegalovirus (125) (140) (124), also strongly 
suggest that B virus has likely undergone parallel selection that enables manipulation of 
host genes involved with antiviral defenses.  
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Kinetic analysis of microarray data: observations of dynamic virus: host 
interactions 
In the microarray studies presented in this dissertation, early host cellular 
responses induced by two closely neuroinvasive alphaherpesviruses, B virus and HSV-1, 
were comparatively analyzed in a common cell type, human foreskin fibroblasts, at 
different time points during the first 5 hours of infection, including at the time of virus 
attachment to cells. Although these cells showed almost no measurable changes during 
virus attachment of either B virus or HSV-1, there was one gene, IL-6ST, induced by 
each virus. This gene encodes the transducer chain shared by many cytokines, including 
IL-6, IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM) and ciliary 
neurotrophic factor (CNTF). All of these cytokines act via a receptor complex in which 
signaling is triggered by homodimerization or heterodimerization with gp130. 
Downstream of this cytokine-IL-6ST pathway, a variety of biochemical events take 
place, including activation of cytoplasmic tyrosine kinases that are associated with IL-
6ST and modification of transcription factors. To monitor whether virus attachment 
induces any host gene expression, an alternative experimental design to performing virus 
adsorption at 4°C, preventing virus penetration, U.V. inactivated virus can be utilized in 
future studies.  
 
The observation that increased expression of only three genes occurred at 3 h p.i. 
and 31 genes at 5 h p.i., decreased expression of 27 genes at 3 h p.i. and 742 genes at 5 h 
p.i. that overlapped between B virus and HSV-1 infected cells (Fig 3) demonstrated that 
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cellular gene expression patterns began to be remodeled differentially between B virus 
and HSV-1 shortly after viruses entered into cells. Although most host genes expressed 
following B virus and HSV-1 infection were different, the majority of them can still be 
grouped according to similar functions, e.g., gene expression, cell-to-cell signaling and 
interaction, cellular functions, nervous system development and function, and tissue 
morphology (data not shown).  
 
B virus appeared to down-regulate fewer host genes than HSV-1  (Fig 2).  It is not 
clear why human host cells respond to these two similar simplexviruses so differently 
with regard down-regulation of host genes. Alphaherpesviruses encode a structural 
protein, the virion host shutoff (vhs) protein, which stimulates nonspecific degradation of 
cellular mRNA, inhibiting host cell protein synthesis during the early virus infection. 
Perhaps B virus vhs function is not as efficient as HSV-1, or the human host cell RNAs 
are more resistant to B virus vhs degradation. Another possibility is that B virus does not 
activate transcriptional repressors as HSV-1 does to shut down host cell gene 
transcription in human cells.  
 
 
The lack of innate immune responses in B virus infected cells: stealth virus in the 
environment of the foreign host cell. 
To differentiate early host innate responses following B virus or HSV-1 infection 
in human cells, innate immune response genes were sorted from the microarray data to 
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run hierarchical cluster analysis. The studies described in this dissertation show for the 
first time that B virus infection results in the expression of almost no innate immunity 
related genes, e.g., to the IFN signaling pathway, cytokine or chemokine production. On 
the other hand, HSV-1 infection of human cells was followed by host expression of 
CXCL1, CXCL2, CXCL3, CXCL6, CXCL8 (IL-8), CCL2, IL-1", IL-6, IL-11, IRF-1, 
IFNAR2 and SOCS3 etc., which are involved in chemotaxis, inflammation, and immune 
cell proliferation (Fig 7 & 8). The observations in HSV-1-infected cells agreed with other 
published microarray data (151) showing that HSV-1 infection results in a strong host 
cell responses in the natural host cells, but this study also demonstrates for the first time 
that host cells infected with B virus appear, within the first five hours, not to respond as if 
infected. The implication is that B virus can mask its presence in human cells, especially 
in the early stages of infection, allowing B virus to proceed unimpeded by the innate 
defenses of the target cell. How this facilitates the dramatic pathogenesis of the virus in 
foreign hosts will certainly be  the topic of many future studies. In contrast, host cells 
infected with HSV-1 responded measurably to infection, and in turn HSV-1 induced 
suppressor of cytokine signaling-3 (SOCS3), a host cell negative regulator of the JAK-
SATA pathway to inhibit antiviral gene expression (Fig 7) (172). These events reflect the 
orchestrated events within in host cell that has adapted to a specific virus infection. 
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Sequence of events from cytoplasm to nucleus during the course of virus infection 
(Virus-specific regulation of the host cell NF-#B pathway) 
 Regardless of the differences in host gene remodeling following each virus 
infection, nalyses of microarray data revealed that shortly after the onset of infection, NF-
#B signaling pathways were engaged following either virus infection in human cells, i.e., 
p50 was translocated to the nucleus and bound to the canonical p65/p50 promoter to drive 
the expression of NF-#B target genes. The stimuli that triggered these events following B 
virus infection are unknown, but investigators have shown that HSV-1 can utilize TLR2, 
TLR9, gD-HveA binding or the expression of ICP4 and ICP27 to activate NF-#B (110) 
(83) (98, 122). If the NF-#B, p65/p50 translocation is seen in either virus infection of 
human cells, what causes the differential activation of cytokine transcription? Recent 
identification of a negative regulator of p50 binding activity in the nucleus, I#B$, was 
evaluated. Examination of each virus infection revealed that there was differential 
regulation of the gene encoding I#B$, thus this candidate protein was investigated as part 
of these studies. 
 
To further understand the role of I#B$ as a negative regulator of NF-#B p50 
blocking NF-#B DNA binding activity (155) (169) (171), I#B$ was silenced. This 
resulted in the induction of the expression of a set of cytokine and chemokine genes, 
including CCL2, CXCL1, and CXCL3, in B virus infected humans cells, making I#B$ a 
candidate inhibitor of host innate response genes. Other genes, however, including IL-6, 
CXCL2, Il-8 were not restored upon silencing the I#B$ gene in the B virus infected 
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HFFs.  Either the remaining I#B$ activity (knockdown rate was 71%) was able to block 
binding of p65/p50 transactivation of cytokines, or an I#B$-independent mechanism 
exists to regulate specific cytokine genes. In I#B$ knockout mice, investigators have 
shown that I#B$ is involved in NF-#B dependent activation of IL-6 by functioning as a 
coactivator (169). It is therefore intriguing to speculate that B virus induced I#B$ 
functions not only as an inhibitor, but also as a coactivator to regulate NF-#B dependent 
genes expression. Due to the various promoter sequences specific in different NF-#B 
target genes, the role of I#B$ in regulating transcriptional activity of each NF-#B target 
genes is likely gene-specific.  
 
Since HSV-1 infection also resulted in I#B$ induction in HFF cells, these studies 
evaluated other regulators of cytokine genes. Besides I#B$, NF-#B negative regulators 
I#B! (NFKBIA), IkB% (NFKBIE), and BCL-3 were found to be induced in HSV-1 
infected cells. This feedback inhibition presumably is destined to restore the inhibited 
NF-#B state, thereby, controlling the NF-#B regulated genes to block apoptotic 
functions. Meanwhile, many other NF#B genes including p100 (p52 precursor), p105 
(p50 precursor), REL, and RelB were all induced by HSV-1, but not by B virus. Induced 
expression of the NF-#B genes is thought to replenish NF-#B in the nuclei to compensate 
for the activity of NF-#B blocked by I#B$. This may be one explanation for the 
observation that expression of NF-#B regulated innate immune response genes were not 
inhibited in HSV-1 infected human cells. 
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Another factor that may play a role in HSV-1 infected cells is the cytokine IL-1", 
which can activate the NF-#B signaling pathway. This results in expression of various 
inflammation- and innate immunity-related genes that continuously up-regulate the 
induction of cytokines or chemokines. Although IL-1" was not induced in microarray 
data, real-time RT-PCR data showed that IL-1" was highly induced (> 6.9- to 31-fold) by 
HSV-1. This discrepancy may be because that IL-1" gene has splice variants and the 
cDNA probe sets on the Affymetrix chip can not detect IL-1" well. On the other hand, no 
IL-1" was found to be induced in B virus-infected cells either by microarray or real-time 
RT-PCR analysis. The lack of IL-1" induction in B virus-infected cells may contribute to 
the lack of cytokine and chemokine induction. 
 
 
Neutrophil chemotaxis during virus infection provides inflammatory responses that 
dampen virus replication. 
Based on the microarray data and neutrophil transmigration result shown in Fig. 
8, HFFs secreted cytokines and chemokines, e.g., IL-6, IL-8, CXCL1, CXCL2, CXCL3 
and CCL2 to induce neutrophil chemotaxis after HSV-1 infection, but not after B virus 
infection. This suggests that in our in vitro HSV-1 natural host cells model, innate 
immune response system includes infiltration of inflammatory cells into the virus 
infected sites. There was a basal level of chemoattractant activity found in mock-infected 
cell supernatants leading to neutrophil transmigration. It has been reported that 
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mitochondrial derived peptides, e.g., mitochondrial encoded NADH dehydrogenase 
subunit 1 (ND1), are potent chemotactic ligands that initiate neutrophil signaling 
pathways (146). Therefore, it is possible that the release of these mitochondrial derived 
peptides from disintegrating mitochondria is responsible for the observation that mock-
infected cell supernatants had low levels of chemoattractant activity.  
The foreign host cell model for B virus infection revealed that infected HFFs 
lacked the abilities to produce chemoattractant cytokines or chemokines. This is 
intriguing because this suggests that B virus is able to escape host immune response 
surveillance at early time points following infection. The induction of I#B$ to block NF-
#B dependent transcriptional activity may explain why there is no chemoattractant 
cytokine or chemokine production post B virus infection. Experimental evidence did not 
rule out the possibility that B virus also produced some negative chemoattractant 
regulator to block neutrophil transmigration, since mock-infected cell supernatants were 
found to have greater chemoattractant activity than B virus-infected cell supernatant. To 
further confirm the neutrophil chemoattractant inhibitory effect in B virus-infected HFFs 
supernatants was due to an unidentified inhibitor(s) produced by B virus, strong 
neutrophil chemoattractants, IL-8 and f-MLP, were added to B virus-infected HFF 
supernatant separately to perform neutrophil transmigration assay. The results indicated 
that B virus inhibited both IL-8 and fMLP-mediated neutrophils transmigration. 
Interestingly, mock-infected cell supernatants inhibited both IL-8 and fMLP-mediated 
neutrophil transmigration rates as well. It is still unknown what chemotactic inhibitor(s) 
are produced by fibroblasts under the conditions of B virus infection or mock-infection. 
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But fibroblasts might be prompted to produce chemotactic inhibitors as a result of stress 
due to growth in serum-free medium. HSV-1 infected cell supernatants reduced 
chemotaxis relative to controls, but significantly less effectively than B virus inhibition of 
IL-8-mediated neutrophil transmigration (Fig 15). These observations may be explained 
by the observations that HSV-1 infected cells derived chemoattractants desensitized G 
protein coupled chemoattractant receptors on the cell surfaces. On the other hand, the 
addition of fMLP to HSV-1 infected cell supernatants did not inhibit neutrophil 
transmigration in later time points (i.e. 5 h p.i.) (Fig 16), implying that fMLP-mediated 
neutrophil migration signaling pathway was not affected and remained functional.  
Neutrophil infiltration has been observed in HSV-1 infection in keratinocytes and 
corneal epithelial cells (102) (156) (106). Severe HSV-1 infections are observed in 
corneas and footpads of mice depleted of neutrophils (156) (160). It has also been shown 
that there is a high incidence of HSV-1 infection in patients rendered neutropenic as a 
result of chemotherapy (8) (78). Neutrophils mediated protection against HSV-1 via 
several mechanisms, including antibody-dependent cellular cytotoxicity, Fc-mediated 
phagocytosis, complement dependent chemotaxis and phagocytosis. Neutrophil can 
directly inactivate HSV-1 by realeasing defensin or reactive oxygen species (54) (168). 
Neutrophils may also exert their antiviral effects indirectly by producing chemokines or 
cytokines, which in turn recruit other effector cells, such as T cells, macrophages and NK 
cells to the site of virus infection to participate in nonspecific or specific antiviral defense 
mechanisms (25). The data presented in this dissertation showed that HFFs did not 
respond to B virus infection by inducing any chemokines or cytokines with 
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chemoattractant activity, while HFFs responded to HSV-1 and induced neutrophil 
chemotaxis. These data support that neutrophils play an important role in the innate 
immunity/inflammatory to control/restrict virus invasion of adjacent c natural host cells, 
but not in the environment of foreign host cells.  
 
Conclusion 
Overall, the study of early cell signaling events following B virus and HSV-1 
infection provides the foundation for future studies to unravel the subsequent cellular 
events that can provide a better understanding of what causes different disease outcomes 
as a result of the same virus infection in different host systems. HSV-1 infection not only 
induces innate immune responsive genes in human cells, but it also has mechanisms for 
overcoming the host defense system. This likely reflects the evolution of HSV-1 with 
human cells, resulting in the virus’ capability to establish life-long latent infection. B 
virus, however, utilizes I#B$ as a direct way to block the induction of NF-#B target 
genes, thereby inhibiting human host innate immune responses. Ultimately, this may lead 
to the inability of B virus to coexist within human hosts. Because innate immunity is 
critical for the generation of effective adaptive immune responses, the block of NF-#B 
may prove to be a major correlate in the severe morbidity and mortality resulting from 
human B virus infection. Ultimately, this dissertation provided the opportunities to 
investigate the differences in virus behavior within natural and foreign host 
microenvironments, paving the way for utilizing this system to identify critical targets of 
B virus infection. Identification of these targets furthers the understanding of how 
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emerging and re-emerging viruses may behave in foreign hosts, and additionally provides 
invaluable information for control of virus infections in foreign versus natural hosts. 
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